BR112019018774A2 - composto tendo uma estrutura de acordo com a fórmula i, sal farmaceuticamente aceitável, composição farmacêutica, método para prevenir ou tratar uma doença ou afeção e método para imunomodulação, inibição ou prevenção de rejeição de enxertos de órgãos ou pele ou tratamento de tumores ou câncer - Google Patents
composto tendo uma estrutura de acordo com a fórmula i, sal farmaceuticamente aceitável, composição farmacêutica, método para prevenir ou tratar uma doença ou afeção e método para imunomodulação, inibição ou prevenção de rejeição de enxertos de órgãos ou pele ou tratamento de tumores ou câncer Download PDFInfo
- Publication number
- BR112019018774A2 BR112019018774A2 BR112019018774A BR112019018774A BR112019018774A2 BR 112019018774 A2 BR112019018774 A2 BR 112019018774A2 BR 112019018774 A BR112019018774 A BR 112019018774A BR 112019018774 A BR112019018774 A BR 112019018774A BR 112019018774 A2 BR112019018774 A2 BR 112019018774A2
- Authority
- BR
- Brazil
- Prior art keywords
- methyl
- mmol
- tert
- ethoxymethyl
- petition
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 180
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 37
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 11
- 201000011510 cancer Diseases 0.000 title claims abstract description 6
- 238000000034 method Methods 0.000 title claims description 98
- 150000003839 salts Chemical class 0.000 title claims description 33
- 201000010099 disease Diseases 0.000 title claims description 17
- 230000003405 preventing effect Effects 0.000 title claims description 8
- 210000000056 organ Anatomy 0.000 title claims description 7
- 230000002519 immonomodulatory effect Effects 0.000 title claims description 6
- 239000008194 pharmaceutical composition Substances 0.000 title description 12
- 230000002401 inhibitory effect Effects 0.000 title description 3
- 208000035475 disorder Diseases 0.000 claims abstract description 20
- 238000011282 treatment Methods 0.000 claims abstract description 20
- 208000002193 Pain Diseases 0.000 claims abstract description 18
- 230000036407 pain Effects 0.000 claims abstract description 18
- 206010013663 drug dependence Diseases 0.000 claims abstract description 8
- 208000011117 substance-related disease Diseases 0.000 claims abstract description 8
- 208000007848 Alcoholism Diseases 0.000 claims abstract description 7
- 201000004681 Psoriasis Diseases 0.000 claims abstract description 7
- 208000019622 heart disease Diseases 0.000 claims abstract description 7
- 208000020446 Cardiac disease Diseases 0.000 claims abstract description 6
- 208000003870 Drug Overdose Diseases 0.000 claims abstract description 6
- 206010033296 Overdoses Diseases 0.000 claims abstract description 6
- 201000001880 Sexual dysfunction Diseases 0.000 claims abstract description 6
- 231100000725 drug overdose Toxicity 0.000 claims abstract description 6
- 231100000872 sexual dysfunction Toxicity 0.000 claims abstract description 6
- 208000028774 intestinal disease Diseases 0.000 claims abstract description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 348
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 163
- 239000000203 mixture Substances 0.000 claims description 101
- 125000000217 alkyl group Chemical group 0.000 claims description 41
- 125000003118 aryl group Chemical group 0.000 claims description 31
- 125000001424 substituent group Chemical group 0.000 claims description 28
- 125000001072 heteroaryl group Chemical group 0.000 claims description 23
- 125000004404 heteroalkyl group Chemical group 0.000 claims description 20
- 229920006395 saturated elastomer Polymers 0.000 claims description 20
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 19
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 14
- 230000001404 mediated effect Effects 0.000 claims description 9
- 206010012735 Diarrhoea Diseases 0.000 claims description 8
- 208000018522 Gastrointestinal disease Diseases 0.000 claims description 7
- 206010020853 Hypertonic bladder Diseases 0.000 claims description 7
- 208000009722 Overactive Urinary Bladder Diseases 0.000 claims description 7
- 206010046543 Urinary incontinence Diseases 0.000 claims description 7
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 7
- 208000002551 irritable bowel syndrome Diseases 0.000 claims description 7
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 7
- 208000020629 overactive bladder Diseases 0.000 claims description 7
- 206010011224 Cough Diseases 0.000 claims description 6
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 6
- 208000018737 Parkinson disease Diseases 0.000 claims description 6
- 206010037423 Pulmonary oedema Diseases 0.000 claims description 6
- 208000004756 Respiratory Insufficiency Diseases 0.000 claims description 6
- 206010038678 Respiratory depression Diseases 0.000 claims description 6
- 206010003246 arthritis Diseases 0.000 claims description 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 6
- 208000006673 asthma Diseases 0.000 claims description 6
- 230000005961 cardioprotection Effects 0.000 claims description 6
- 201000006549 dyspepsia Diseases 0.000 claims description 6
- 206010036596 premature ejaculation Diseases 0.000 claims description 6
- 208000005333 pulmonary edema Diseases 0.000 claims description 6
- 230000004202 respiratory function Effects 0.000 claims description 6
- 230000001562 ulcerogenic effect Effects 0.000 claims description 6
- 210000003932 urinary bladder Anatomy 0.000 claims description 6
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 5
- 206010069632 Bladder dysfunction Diseases 0.000 claims description 5
- 206010065390 Inflammatory pain Diseases 0.000 claims description 5
- 208000000693 Neurogenic Urinary Bladder Diseases 0.000 claims description 5
- 206010029279 Neurogenic bladder Diseases 0.000 claims description 5
- 208000001294 Nociceptive Pain Diseases 0.000 claims description 5
- 208000003251 Pruritus Diseases 0.000 claims description 5
- 206010047700 Vomiting Diseases 0.000 claims description 5
- 206010000496 acne Diseases 0.000 claims description 5
- 230000036592 analgesia Effects 0.000 claims description 5
- 208000010877 cognitive disease Diseases 0.000 claims description 5
- 230000004064 dysfunction Effects 0.000 claims description 5
- 230000003137 locomotive effect Effects 0.000 claims description 5
- 230000004899 motility Effects 0.000 claims description 5
- 208000020016 psychiatric disease Diseases 0.000 claims description 5
- 230000028327 secretion Effects 0.000 claims description 5
- 208000005615 Interstitial Cystitis Diseases 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 4
- 125000002619 bicyclic group Chemical group 0.000 claims description 4
- 230000005764 inhibitory process Effects 0.000 claims description 4
- 230000002981 neuropathic effect Effects 0.000 claims description 4
- 230000002265 prevention Effects 0.000 claims description 4
- 206010040882 skin lesion Diseases 0.000 claims description 4
- 231100000444 skin lesion Toxicity 0.000 claims description 4
- 206010000060 Abdominal distension Diseases 0.000 claims description 3
- 125000002618 bicyclic heterocycle group Chemical group 0.000 claims description 3
- 125000001153 fluoro group Chemical group F* 0.000 claims description 3
- 125000005330 8 membered heterocyclic group Chemical group 0.000 claims description 2
- 229910006074 SO2NH2 Inorganic materials 0.000 claims description 2
- 206010058141 Skin graft rejection Diseases 0.000 claims description 2
- 239000002131 composite material Substances 0.000 claims 3
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims 1
- 235000019000 fluorine Nutrition 0.000 claims 1
- -1 polycyclic amines Chemical class 0.000 abstract description 284
- 108090000137 Opioid Receptors Proteins 0.000 abstract description 17
- 102000003840 Opioid Receptors Human genes 0.000 abstract description 17
- 239000003814 drug Substances 0.000 abstract description 10
- 229940079593 drug Drugs 0.000 abstract description 9
- 230000001225 therapeutic effect Effects 0.000 abstract description 8
- 238000002560 therapeutic procedure Methods 0.000 abstract description 5
- 201000007930 alcohol dependence Diseases 0.000 abstract description 2
- 208000012902 Nervous system disease Diseases 0.000 abstract 1
- 208000025966 Neurological disease Diseases 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- 230000002485 urinary effect Effects 0.000 abstract 1
- 238000005481 NMR spectroscopy Methods 0.000 description 453
- OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 description 402
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 description 285
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 234
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 196
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 192
- 239000000243 solution Substances 0.000 description 179
- 238000002360 preparation method Methods 0.000 description 163
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 143
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 141
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 120
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 109
- 238000006243 chemical reaction Methods 0.000 description 100
- 235000019439 ethyl acetate Nutrition 0.000 description 97
- 239000011541 reaction mixture Substances 0.000 description 94
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 84
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 81
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 79
- 239000012074 organic phase Substances 0.000 description 74
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 73
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 65
- 239000011734 sodium Substances 0.000 description 60
- 230000015572 biosynthetic process Effects 0.000 description 58
- 238000010898 silica gel chromatography Methods 0.000 description 58
- 238000003786 synthesis reaction Methods 0.000 description 56
- 230000002829 reductive effect Effects 0.000 description 49
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 48
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 46
- 239000007832 Na2SO4 Substances 0.000 description 46
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 46
- 229910052938 sodium sulfate Inorganic materials 0.000 description 46
- 235000011152 sodium sulphate Nutrition 0.000 description 46
- 239000007787 solid Substances 0.000 description 44
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 41
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 40
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 33
- 239000003921 oil Substances 0.000 description 32
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 30
- 239000012267 brine Substances 0.000 description 30
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 30
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 26
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 26
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 25
- 238000009472 formulation Methods 0.000 description 25
- 239000012299 nitrogen atmosphere Substances 0.000 description 24
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 24
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 22
- 238000003756 stirring Methods 0.000 description 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 20
- 239000007864 aqueous solution Substances 0.000 description 20
- 239000012230 colorless oil Substances 0.000 description 20
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- 239000002253 acid Substances 0.000 description 17
- 238000004440 column chromatography Methods 0.000 description 16
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 16
- 239000000543 intermediate Substances 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- METKIMKYRPQLGS-UHFFFAOYSA-N atenolol Chemical compound CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-UHFFFAOYSA-N 0.000 description 15
- 239000012044 organic layer Substances 0.000 description 15
- 241001465754 Metazoa Species 0.000 description 14
- 238000000746 purification Methods 0.000 description 14
- 239000013543 active substance Substances 0.000 description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 239000012298 atmosphere Substances 0.000 description 12
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 12
- 239000003826 tablet Substances 0.000 description 12
- 239000002585 base Substances 0.000 description 11
- 239000000460 chlorine Substances 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- 239000000651 prodrug Substances 0.000 description 11
- 229940002612 prodrug Drugs 0.000 description 11
- 239000000377 silicon dioxide Substances 0.000 description 11
- 239000000306 component Substances 0.000 description 10
- 238000001816 cooling Methods 0.000 description 10
- 239000012043 crude product Substances 0.000 description 10
- 150000002148 esters Chemical class 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 229910052757 nitrogen Inorganic materials 0.000 description 10
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 239000000725 suspension Substances 0.000 description 10
- 229910017917 NH4 Cl Inorganic materials 0.000 description 9
- 230000029936 alkylation Effects 0.000 description 9
- 238000005804 alkylation reaction Methods 0.000 description 9
- 239000002552 dosage form Substances 0.000 description 9
- 238000001914 filtration Methods 0.000 description 9
- 125000005842 heteroatom Chemical group 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 9
- 238000005160 1H NMR spectroscopy Methods 0.000 description 8
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 8
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 8
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 8
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 description 8
- OKKJLVBELUTLKV-MZCSYVLQSA-N Deuterated methanol Chemical compound [2H]OC([2H])([2H])[2H] OKKJLVBELUTLKV-MZCSYVLQSA-N 0.000 description 8
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 8
- 239000000706 filtrate Substances 0.000 description 8
- 150000003949 imides Chemical class 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- NYCVCXMSZNOGDH-UHFFFAOYSA-N pyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CCCC1 NYCVCXMSZNOGDH-UHFFFAOYSA-N 0.000 description 8
- 102000005962 receptors Human genes 0.000 description 8
- 108020003175 receptors Proteins 0.000 description 8
- CYVGILHLWQNOBS-UHFFFAOYSA-N 3-(ethoxymethyl)-3-(2-phenylethyl)pyrrolidine Chemical compound C(C)OCC1(CNCC1)CCC1=CC=CC=C1 CYVGILHLWQNOBS-UHFFFAOYSA-N 0.000 description 7
- 230000003502 anti-nociceptive effect Effects 0.000 description 7
- 229910052794 bromium Inorganic materials 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000001257 hydrogen Substances 0.000 description 7
- 229910052739 hydrogen Inorganic materials 0.000 description 7
- 125000004192 tetrahydrofuran-2-yl group Chemical group [H]C1([H])OC([H])(*)C([H])([H])C1([H])[H] 0.000 description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 6
- 101150041968 CDC13 gene Proteins 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 6
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 6
- 150000001299 aldehydes Chemical class 0.000 description 6
- 239000002775 capsule Substances 0.000 description 6
- 238000010511 deprotection reaction Methods 0.000 description 6
- NKLCNNUWBJBICK-UHFFFAOYSA-N dess–martin periodinane Chemical compound C1=CC=C2I(OC(=O)C)(OC(C)=O)(OC(C)=O)OC(=O)C2=C1 NKLCNNUWBJBICK-UHFFFAOYSA-N 0.000 description 6
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 229910052740 iodine Inorganic materials 0.000 description 6
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 6
- HRDXJKGNWSUIBT-UHFFFAOYSA-N methoxybenzene Chemical group [CH2]OC1=CC=CC=C1 HRDXJKGNWSUIBT-UHFFFAOYSA-N 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 238000012746 preparative thin layer chromatography Methods 0.000 description 6
- 238000010992 reflux Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 229910052717 sulfur Inorganic materials 0.000 description 6
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 6
- OISVCGZHLKNMSJ-UHFFFAOYSA-N 2,6-Lutidine Substances CC1=CC=CC(C)=N1 OISVCGZHLKNMSJ-UHFFFAOYSA-N 0.000 description 5
- MDAFBEWPTWHTDI-UHFFFAOYSA-N 4-(ethoxymethyl)-4-(2-phenylethyl)piperidine Chemical compound C(C)OCC1(CCNCC1)CCC1=CC=CC=C1 MDAFBEWPTWHTDI-UHFFFAOYSA-N 0.000 description 5
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical class N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 5
- XDMHAZLUJIOTER-UHFFFAOYSA-N CCOCC1(CCC2=CC=CC=C2)C=NC=C1 Chemical compound CCOCC1(CCC2=CC=CC=C2)C=NC=C1 XDMHAZLUJIOTER-UHFFFAOYSA-N 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 5
- 125000003545 alkoxy group Chemical group 0.000 description 5
- 125000002947 alkylene group Chemical group 0.000 description 5
- 230000037396 body weight Effects 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229910052801 chlorine Inorganic materials 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 229910052731 fluorine Inorganic materials 0.000 description 5
- 239000011737 fluorine Substances 0.000 description 5
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 5
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 5
- 239000002480 mineral oil Substances 0.000 description 5
- 235000010446 mineral oil Nutrition 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 5
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 description 5
- 229910000027 potassium carbonate Inorganic materials 0.000 description 5
- 238000011321 prophylaxis Methods 0.000 description 5
- 239000012279 sodium borohydride Substances 0.000 description 5
- 229910000033 sodium borohydride Inorganic materials 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 235000017550 sodium carbonate Nutrition 0.000 description 5
- 238000007920 subcutaneous administration Methods 0.000 description 5
- AVKGWIIDAAHHQG-UHFFFAOYSA-N tert-butyl 4-formyl-4-(2-phenylethyl)piperidine-1-carboxylate Chemical compound C(=O)C1(CCN(CC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 AVKGWIIDAAHHQG-UHFFFAOYSA-N 0.000 description 5
- IWYWGPKMUUVSSB-GOSISDBHSA-N (3R)-1-[(2-methylpropan-2-yl)oxycarbonyl]-3-(phenylmethoxymethyl)pyrrolidine-3-carboxylic acid Chemical compound C(C1=CC=CC=C1)OC[C@@]1(CN(CC1)C(=O)OC(C)(C)C)C(=O)O IWYWGPKMUUVSSB-GOSISDBHSA-N 0.000 description 4
- IBNSMXVRMZAJQC-UHFFFAOYSA-N 1-[(2-methylpropan-2-yl)oxycarbonyl]-4-(2-phenylethyl)piperidine-4-carboxylic acid Chemical compound CC(C)(C)OC(=O)N1CCC(CCC2=CC=CC=C2)(CC1)C(O)=O IBNSMXVRMZAJQC-UHFFFAOYSA-N 0.000 description 4
- NJFACNDHGKAHGU-UHFFFAOYSA-N 3-[1-[3-(ethoxymethyl)-3-(2-phenylethyl)pyrrolidin-1-yl]ethyl]pyridine Chemical compound C(C)OCC1(CN(CC1)C(C)C=1C=NC=CC=1)CCC1=CC=CC=C1 NJFACNDHGKAHGU-UHFFFAOYSA-N 0.000 description 4
- CELKOWQJPVJKIL-UHFFFAOYSA-N 3-fluoropyridine Chemical compound FC1=CC=CN=C1 CELKOWQJPVJKIL-UHFFFAOYSA-N 0.000 description 4
- NKZTZJXCPDUAHT-UHFFFAOYSA-N 4-(ethoxymethyl)-4-(2-phenylethyl)azepane Chemical compound C(C)OCC1(CCNCCC1)CCC1=CC=CC=C1 NKZTZJXCPDUAHT-UHFFFAOYSA-N 0.000 description 4
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- 101000797623 Homo sapiens Protein AMBP Proteins 0.000 description 4
- 102400001240 Inter-alpha-trypsin inhibitor light chain Human genes 0.000 description 4
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 4
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 4
- 241000009298 Trigla lyra Species 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000000556 agonist Substances 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- 239000005557 antagonist Substances 0.000 description 4
- 125000004429 atom Chemical group 0.000 description 4
- 125000005605 benzo group Chemical group 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 125000000623 heterocyclic group Chemical group 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- WFKAJVHLWXSISD-UHFFFAOYSA-N isobutyramide Chemical compound CC(C)C(N)=O WFKAJVHLWXSISD-UHFFFAOYSA-N 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 4
- 235000015320 potassium carbonate Nutrition 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- WGMOWCAMLKSCAP-UHFFFAOYSA-N tert-butyl 4-(oxiran-2-yl)-4-(2-phenylethyl)piperidine-1-carboxylate Chemical compound O1C(C1)C1(CCN(CC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 WGMOWCAMLKSCAP-UHFFFAOYSA-N 0.000 description 4
- RQCNHUCCQJMSRG-UHFFFAOYSA-N tert-butyl piperidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCCC1 RQCNHUCCQJMSRG-UHFFFAOYSA-N 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- CVQUIXMHNWJFGY-UHFFFAOYSA-N (2,5-dimethylthiophen-3-yl)methanol Chemical compound CC1=CC(CO)=C(C)S1 CVQUIXMHNWJFGY-UHFFFAOYSA-N 0.000 description 3
- MBIZXFATKUQOOA-UHFFFAOYSA-N 1,3,4-thiadiazole Chemical compound C1=NN=CS1 MBIZXFATKUQOOA-UHFFFAOYSA-N 0.000 description 3
- SCEKDQTVGHRSNS-UHFFFAOYSA-N 1,3,5-trimethyl-2-nitrobenzene Chemical compound CC1=CC(C)=C([N+]([O-])=O)C(C)=C1 SCEKDQTVGHRSNS-UHFFFAOYSA-N 0.000 description 3
- YLIRMFUCKPFQCJ-UHFFFAOYSA-N 1-(ethoxymethyl)-4-(2-phenylethyl)piperidine Chemical compound C(C)OCN1CCC(CC1)CCC1=CC=CC=C1 YLIRMFUCKPFQCJ-UHFFFAOYSA-N 0.000 description 3
- XPIMCSOVBQEIBK-UHFFFAOYSA-N 1-O-tert-butyl 3-O-methyl 3-(2-phenylethyl)pyrrolidine-1,3-dicarboxylate Chemical compound COC(=O)C1(CCC2=CC=CC=C2)CCN(C1)C(=O)OC(C)(C)C XPIMCSOVBQEIBK-UHFFFAOYSA-N 0.000 description 3
- IWYWGPKMUUVSSB-UHFFFAOYSA-N 1-[(2-methylpropan-2-yl)oxycarbonyl]-3-(phenylmethoxymethyl)pyrrolidine-3-carboxylic acid Chemical compound C(C1=CC=CC=C1)OCC1(CN(CC1)C(=O)OC(C)(C)C)C(=O)O IWYWGPKMUUVSSB-UHFFFAOYSA-N 0.000 description 3
- YPHBFHAAMVFUAV-UHFFFAOYSA-N 1-[(3,5-dimethyl-4-nitrophenyl)methyl]-4-(ethoxymethyl)-4-(2-phenylethyl)piperidine Chemical compound CCOCC1(CCC2=CC=CC=C2)CCN(CC2=CC(C)=C(C(C)=C2)[N+]([O-])=O)CC1 YPHBFHAAMVFUAV-UHFFFAOYSA-N 0.000 description 3
- XJUPDKVTKGMJRB-UHFFFAOYSA-N 1-[4-[[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]methyl]phenyl]-3-methylurea Chemical compound CCOCC1(CCC2=CC=CC=C2)CCN(CC2=CC=C(NC(=O)NC)C=C2)CC1 XJUPDKVTKGMJRB-UHFFFAOYSA-N 0.000 description 3
- YBTXLDIVRNXFSD-UHFFFAOYSA-N 1-[4-[[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]methyl]phenyl]ethanone Chemical compound CCOCC1(CCC2=CC=CC=C2)CCN(CC2=CC=C(C=C2)C(C)=O)CC1 YBTXLDIVRNXFSD-UHFFFAOYSA-N 0.000 description 3
- XNEVCYYXSQNJBT-JOCHJYFZSA-N 2-[2-[(3R)-3-(ethoxymethyl)-1-[2-(6-methylpyridin-3-yl)propan-2-yl]pyrrolidin-3-yl]ethyl]-1H-pyrimidin-6-one Chemical compound C(C)OC[C@]1(CN(CC1)C(C)(C)C=1C=NC(=CC=1)C)CCC1=NC=CC(N1)=O XNEVCYYXSQNJBT-JOCHJYFZSA-N 0.000 description 3
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 description 3
- JHQJXBRTXLUDIM-UHFFFAOYSA-N 2-oxo-1,3-dihydrobenzimidazole-5-carbaldehyde Chemical compound O=CC1=CC=C2NC(=O)NC2=C1 JHQJXBRTXLUDIM-UHFFFAOYSA-N 0.000 description 3
- OIYYWEMFPNZCLH-UHFFFAOYSA-N 3-(ethoxymethyl)-3-(2-phenylethyl)azetidine Chemical compound C(C)OCC1(CNC1)CCC1=CC=CC=C1 OIYYWEMFPNZCLH-UHFFFAOYSA-N 0.000 description 3
- UODXWHPNUCOZEZ-UHFFFAOYSA-N 3-bromo-2,5-dimethylthiophene Chemical compound CC1=CC(Br)=C(C)S1 UODXWHPNUCOZEZ-UHFFFAOYSA-N 0.000 description 3
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 3
- MUMITJYYBMXOPJ-UHFFFAOYSA-N 4-(oxetan-2-yl)-4-(2-phenylethyl)piperidine Chemical compound O1C(CC1)C1(CCNCC1)CCC1=CC=CC=C1 MUMITJYYBMXOPJ-UHFFFAOYSA-N 0.000 description 3
- KXMRDHPZQHAXML-UHFFFAOYSA-N 4-[(2-methylpropan-2-yl)oxycarbonylamino]cyclohexane-1-carboxylic acid Chemical compound CC(C)(C)OC(=O)NC1CCC(C(O)=O)CC1 KXMRDHPZQHAXML-UHFFFAOYSA-N 0.000 description 3
- NYRSYBKSWFJMBX-XMMPIXPASA-N 5-[2-[(3R)-3-(ethoxymethyl)-3-(2-phenylethyl)pyrrolidin-1-yl]propan-2-yl]-2-methylpyridine Chemical compound C(C)OC[C@]1(CN(CC1)C(C)(C)C=1C=CC(=NC=1)C)CCC1=CC=CC=C1 NYRSYBKSWFJMBX-XMMPIXPASA-N 0.000 description 3
- VWIGEYVTDXNDHV-UHFFFAOYSA-N 5-bromo-1,3-dihydrobenzimidazol-2-one Chemical compound BrC1=CC=C2NC(=O)NC2=C1 VWIGEYVTDXNDHV-UHFFFAOYSA-N 0.000 description 3
- IMWMEIWYPWVABQ-UHFFFAOYSA-N 6-methylpyridine-3-carbaldehyde Chemical compound CC1=CC=C(C=O)C=N1 IMWMEIWYPWVABQ-UHFFFAOYSA-N 0.000 description 3
- MVIKIZUTCZBDBU-UHFFFAOYSA-N 7-[(4-methoxyphenyl)methyl]-8-methylpurine Chemical compound COC1=CC=C(CN2C(=NC3=NC=NC=C23)C)C=C1 MVIKIZUTCZBDBU-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- IQWSKLAEHWOTJD-WJOKGBTCSA-N 8-[2-[(3R)-3-(ethoxymethyl)-1-[2-(6-methylpyridin-3-yl)propan-2-yl]pyrrolidin-3-yl]ethyl]-7-[(4-methoxyphenyl)methyl]purine Chemical compound C(C)OC[C@]1(CN(CC1)C(C)(C)C=1C=NC(=CC=1)C)CCC1=NC2=NC=NC=C2N1CC1=CC=C(C=C1)OC IQWSKLAEHWOTJD-WJOKGBTCSA-N 0.000 description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 3
- UZQYFLWZKIMYKS-UHFFFAOYSA-N 8-methyl-7h-purine Chemical compound C1=NC=C2NC(C)=NC2=N1 UZQYFLWZKIMYKS-UHFFFAOYSA-N 0.000 description 3
- LSBDFXRDZJMBSC-UHFFFAOYSA-N Amide-Phenylacetic acid Natural products NC(=O)CC1=CC=CC=C1 LSBDFXRDZJMBSC-UHFFFAOYSA-N 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000007821 HATU Substances 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 3
- WQQFNLVPEFBHQF-UHFFFAOYSA-N N-[4-[[3-(ethoxymethyl)-3-(2-phenylethyl)azetidin-1-yl]methyl]phenyl]acetamide Chemical compound C(C)OCC1(CN(C1)CC1=CC=C(C=C1)NC(C)=O)CCC1=CC=CC=C1 WQQFNLVPEFBHQF-UHFFFAOYSA-N 0.000 description 3
- YNMGJXSCJNMTQN-UHFFFAOYSA-N N-[4-[[4-(2-phenylethyl)-4-pyridin-2-ylpiperidin-1-yl]methyl]phenyl]acetamide Chemical compound C1(=CC=CC=C1)CCC1(CCN(CC1)CC1=CC=C(C=C1)NC(C)=O)C1=NC=CC=C1 YNMGJXSCJNMTQN-UHFFFAOYSA-N 0.000 description 3
- JBDFSDPOVNJBGL-UHFFFAOYSA-N N-[4-[[4-(ethoxymethyl)-4-(2-phenylethyl)azepan-1-yl]methyl]phenyl]acetamide Chemical compound C(C)OCC1(CCN(CCC1)CC1=CC=C(C=C1)NC(C)=O)CCC1=CC=CC=C1 JBDFSDPOVNJBGL-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 101100244562 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) oprD gene Proteins 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 150000008064 anhydrides Chemical class 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Chemical compound N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940110456 cocoa butter Drugs 0.000 description 3
- 235000019868 cocoa butter Nutrition 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 238000010168 coupling process Methods 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 108700023159 delta Opioid Receptors Proteins 0.000 description 3
- 102000048124 delta Opioid Receptors Human genes 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 3
- 238000003818 flash chromatography Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 125000001188 haloalkyl group Chemical group 0.000 description 3
- 125000004474 heteroalkylene group Chemical group 0.000 description 3
- 238000005984 hydrogenation reaction Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 150000002576 ketones Chemical class 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 239000007937 lozenge Substances 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 description 3
- MMOWPSXLJVDVNP-UHFFFAOYSA-N methyl 4-(2-methyl-1,3-dioxolan-2-yl)benzoate Chemical compound C1=CC(C(=O)OC)=CC=C1C1(C)OCCO1 MMOWPSXLJVDVNP-UHFFFAOYSA-N 0.000 description 3
- RKOQMDUDKCMVFW-UHFFFAOYSA-N methyl 4-[(2-methylpropan-2-yl)oxycarbonylamino]cyclohexane-1-carboxylate Chemical compound COC(=O)C1CCC(NC(=O)OC(C)(C)C)CC1 RKOQMDUDKCMVFW-UHFFFAOYSA-N 0.000 description 3
- 229920000609 methyl cellulose Polymers 0.000 description 3
- 239000001923 methylcellulose Substances 0.000 description 3
- 235000010981 methylcellulose Nutrition 0.000 description 3
- 238000000465 moulding Methods 0.000 description 3
- DXASQZJWWGZNSF-UHFFFAOYSA-N n,n-dimethylmethanamine;sulfur trioxide Chemical group CN(C)C.O=S(=O)=O DXASQZJWWGZNSF-UHFFFAOYSA-N 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 125000004274 oxetan-2-yl group Chemical group [H]C1([H])OC([H])(*)C1([H])[H] 0.000 description 3
- 239000001301 oxygen Chemical group 0.000 description 3
- IPWFJLQDVFKJDU-UHFFFAOYSA-N pentanamide Chemical compound CCCCC(N)=O IPWFJLQDVFKJDU-UHFFFAOYSA-N 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 150000004714 phosphonium salts Chemical group 0.000 description 3
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- LJXQPZWIHJMPQQ-UHFFFAOYSA-N pyrimidin-2-amine Chemical compound NC1=NC=CC=N1 LJXQPZWIHJMPQQ-UHFFFAOYSA-N 0.000 description 3
- ADPQWEGXWVSSKZ-UHFFFAOYSA-N pyrrolidine-1,3-dicarboxylic acid Chemical compound OC(=O)C1CCN(C(O)=O)C1 ADPQWEGXWVSSKZ-UHFFFAOYSA-N 0.000 description 3
- 230000020341 sensory perception of pain Effects 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 125000000547 substituted alkyl group Chemical group 0.000 description 3
- 125000004434 sulfur atom Chemical group 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- KUQOHLPKSYIDOJ-UHFFFAOYSA-N tert-butyl 3-(3,3-dimethyloxetan-2-yl)-3-(2-phenylethyl)pyrrolidine-1-carboxylate Chemical compound CC1(C(OC1)C1(CN(CC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1)C KUQOHLPKSYIDOJ-UHFFFAOYSA-N 0.000 description 3
- NIBVVLFPMPDXIG-UHFFFAOYSA-N tert-butyl 3-(ethoxymethyl)-3-(2-phenylethyl)azetidine-1-carboxylate Chemical compound C(C)OCC1(CN(C1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 NIBVVLFPMPDXIG-UHFFFAOYSA-N 0.000 description 3
- RMXCUQZNSYFHQI-UHFFFAOYSA-N tert-butyl 3-(hydroxymethyl)-3-(2-phenylethyl)azetidine-1-carboxylate Chemical compound OCC1(CN(C1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 RMXCUQZNSYFHQI-UHFFFAOYSA-N 0.000 description 3
- PCCMXAZQHQDJMJ-UHFFFAOYSA-N tert-butyl 3-(hydroxymethyl)-3-(2-phenylethyl)pyrrolidine-1-carboxylate Chemical compound OCC1(CN(CC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 PCCMXAZQHQDJMJ-UHFFFAOYSA-N 0.000 description 3
- NZZLYNFIQDQWJC-UHFFFAOYSA-N tert-butyl 4-(dimethylcarbamoyl)-4-(2-phenylethyl)piperidine-1-carboxylate Chemical compound C(C)(C)(C)OC(=O)N1CCC(CC1)(CCC1=CC=CC=C1)C(N(C)C)=O NZZLYNFIQDQWJC-UHFFFAOYSA-N 0.000 description 3
- XGGZSYZSIYOEFB-UHFFFAOYSA-N tert-butyl 4-(formamidocarbamoyl)-4-(2-phenylethyl)piperidine-1-carboxylate Chemical compound C(=O)NNC(=O)C1(CCN(CC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 XGGZSYZSIYOEFB-UHFFFAOYSA-N 0.000 description 3
- AULLBVZKCLLACP-UHFFFAOYSA-N tert-butyl 4-(oxetan-2-yl)-4-(2-phenylethyl)piperidine-1-carboxylate Chemical compound O1C(CC1)C1(CCN(CC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 AULLBVZKCLLACP-UHFFFAOYSA-N 0.000 description 3
- OUILGYJQVAMETA-UHFFFAOYSA-N tert-butyl 4-cyano-4-pyridin-2-ylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(C#N)C1=CC=CC=N1 OUILGYJQVAMETA-UHFFFAOYSA-N 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- 125000005309 thioalkoxy group Chemical group 0.000 description 3
- VXUYXOFXAQZZMF-UHFFFAOYSA-N titanium(IV) isopropoxide Chemical compound CC(C)O[Ti](OC(C)C)(OC(C)C)OC(C)C VXUYXOFXAQZZMF-UHFFFAOYSA-N 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 125000004417 unsaturated alkyl group Chemical group 0.000 description 3
- 235000012431 wafers Nutrition 0.000 description 3
- 108020001588 κ-opioid receptors Proteins 0.000 description 3
- 108020001612 μ-opioid receptors Proteins 0.000 description 3
- SSXIOANGZWQLRM-UHFFFAOYSA-N (3,5-dimethyl-4-nitrophenyl)-[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]methanone Chemical compound CC=1C=C(C=C(C=1[N+](=O)[O-])C)C(=O)N1CCC(CC1)(CCC1=CC=CC=C1)COCC SSXIOANGZWQLRM-UHFFFAOYSA-N 0.000 description 2
- IWYWGPKMUUVSSB-SFHVURJKSA-N (3S)-1-[(2-methylpropan-2-yl)oxycarbonyl]-3-(phenylmethoxymethyl)pyrrolidine-3-carboxylic acid Chemical compound C(C1=CC=CC=C1)OC[C@]1(CN(CC1)C(=O)OC(C)(C)C)C(=O)O IWYWGPKMUUVSSB-SFHVURJKSA-N 0.000 description 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 description 2
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 2
- SHKXYMRQBAGEPN-UHFFFAOYSA-N 1-(2-thiophen-2-ylethyl)piperidine Chemical compound C1CCCCN1CCC1=CC=CS1 SHKXYMRQBAGEPN-UHFFFAOYSA-N 0.000 description 2
- DCNXIRPFWJOZNS-UHFFFAOYSA-N 1-O-tert-butyl 3-O-methyl 3-(2-phenylethyl)azetidine-1,3-dicarboxylate Chemical compound C1(=CC=CC=C1)CCC1(CN(C1)C(=O)OC(C)(C)C)C(=O)OC DCNXIRPFWJOZNS-UHFFFAOYSA-N 0.000 description 2
- LUBJCRLGQSPQNN-UHFFFAOYSA-N 1-Phenylurea Chemical compound NC(=O)NC1=CC=CC=C1 LUBJCRLGQSPQNN-UHFFFAOYSA-N 0.000 description 2
- BGYFVOHWJYYBER-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl azepane-1,4-dicarboxylate Chemical compound CCOC(=O)C1CCCN(C(=O)OC(C)(C)C)CC1 BGYFVOHWJYYBER-UHFFFAOYSA-N 0.000 description 2
- HPYNZHMRTTWQTB-UHFFFAOYSA-N 2,3-dimethylpyridine Chemical compound CC1=CC=CN=C1C HPYNZHMRTTWQTB-UHFFFAOYSA-N 0.000 description 2
- MDBIQKVMPZRYIP-UHFFFAOYSA-N 2-[4-(2-phenylethyl)piperidin-4-yl]-1,3,4-thiadiazole Chemical compound C(CC1(CCNCC1)C1=NN=CS1)C1=CC=CC=C1 MDBIQKVMPZRYIP-UHFFFAOYSA-N 0.000 description 2
- IAMRZOPJMBCFRP-UHFFFAOYSA-N 2-[4-[[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]methyl]phenyl]-1,3,4-oxadiazole Chemical compound C(C)OCC1(CCN(CC1)CC1=CC=C(C=C1)C=1OC=NN=1)CCC1=CC=CC=C1 IAMRZOPJMBCFRP-UHFFFAOYSA-N 0.000 description 2
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 2
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 2
- RBAVFNOGEPCOQI-UHFFFAOYSA-N 3,5-dimethyl-4-nitrobenzoic acid Chemical compound CC1=CC(C(O)=O)=CC(C)=C1[N+]([O-])=O RBAVFNOGEPCOQI-UHFFFAOYSA-N 0.000 description 2
- NYEDROBJCDOGEE-UHFFFAOYSA-N 3-(1-chloroethyl)pyridine Chemical compound CC(Cl)C1=CC=CN=C1 NYEDROBJCDOGEE-UHFFFAOYSA-N 0.000 description 2
- OQTXENMKMAORGK-UHFFFAOYSA-N 3-(bromomethyl)-2,5-dimethylthiophene Chemical compound CC1=CC(CBr)=C(C)S1 OQTXENMKMAORGK-UHFFFAOYSA-N 0.000 description 2
- UWSONZCNXUSTKW-UHFFFAOYSA-N 4,5-Dimethylthiazole Chemical compound CC=1N=CSC=1C UWSONZCNXUSTKW-UHFFFAOYSA-N 0.000 description 2
- QCBSHOMDNLCSSL-UHFFFAOYSA-N 4-(2-methyl-1,3-dioxolan-2-yl)benzaldehyde Chemical compound C=1C=C(C=O)C=CC=1C1(C)OCCO1 QCBSHOMDNLCSSL-UHFFFAOYSA-N 0.000 description 2
- WFTPSTRUUZKFRH-UHFFFAOYSA-N 4-(2-phenylethyl)piperidine Chemical compound C1CNCCC1CCC1=CC=CC=C1 WFTPSTRUUZKFRH-UHFFFAOYSA-N 0.000 description 2
- UZQDUXAJFTWMDT-UHFFFAOYSA-N 4-(2-trimethylsilylethynyl)benzaldehyde Chemical compound C[Si](C)(C)C#CC1=CC=C(C=O)C=C1 UZQDUXAJFTWMDT-UHFFFAOYSA-N 0.000 description 2
- LDKXNRIJKBLWDA-UHFFFAOYSA-N 4-(ethoxymethyl)-1-[2-(4-nitrophenyl)ethyl]-4-(2-phenylethyl)piperidine Chemical compound C(C)OCC1(CCN(CC1)CCC1=CC=C(C=C1)[N+](=O)[O-])CCC1=CC=CC=C1 LDKXNRIJKBLWDA-UHFFFAOYSA-N 0.000 description 2
- QGEBENWTPSTZQI-UHFFFAOYSA-N 4-(ethoxymethyl)-1-[[4-(3-ethoxy-1H-1,2,4-triazol-5-yl)phenyl]methyl]-4-(2-phenylethyl)piperidine Chemical compound CCOCC1(CCC2=CC=CC=C2)CCN(CC2=CC=C(C=C2)C2=NN=C(N2)OCC)CC1 QGEBENWTPSTZQI-UHFFFAOYSA-N 0.000 description 2
- STXGVTIXQLGJQH-UHFFFAOYSA-N 4-(ethoxymethyl)-4-(2-phenylethyl)-1-[[4-(2H-triazol-4-yl)phenyl]methyl]piperidine Chemical compound CCOCC1(CCC2=CC=CC=C2)CCN(CC2=CC=C(C=C2)C2=NNN=C2)CC1 STXGVTIXQLGJQH-UHFFFAOYSA-N 0.000 description 2
- SKLUWKYNZNXSLX-UHFFFAOYSA-N 4-Acetamidobenzaldehyde Chemical compound CC(=O)NC1=CC=C(C=O)C=C1 SKLUWKYNZNXSLX-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- LQERKNMMVCDNAT-UHFFFAOYSA-N 4-[2-[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]ethyl]aniline Chemical compound CCOCC1(CCc2ccccc2)CCN(CCc2ccc(N)cc2)CC1 LQERKNMMVCDNAT-UHFFFAOYSA-N 0.000 description 2
- SRNUIMAMEKMAFS-UHFFFAOYSA-N 4-[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]aniline Chemical compound C(C)OCC1(CCN(CC1)C1=CC=C(C=C1)N)CCC1=CC=CC=C1 SRNUIMAMEKMAFS-UHFFFAOYSA-N 0.000 description 2
- RKQIJSRLIQSAHN-UHFFFAOYSA-N 4-[[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]methyl]aniline Chemical compound C(C)OCC1(CCN(CC1)CC1=CC=C(N)C=C1)CCC1=CC=CC=C1 RKQIJSRLIQSAHN-UHFFFAOYSA-N 0.000 description 2
- FRCPHQQQKWFNDM-UHFFFAOYSA-N 4-[[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]methyl]benzohydrazide Chemical compound C(C)OCC1(CCN(CC1)CC1=CC=C(C(=O)NN)C=C1)CCC1=CC=CC=C1 FRCPHQQQKWFNDM-UHFFFAOYSA-N 0.000 description 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 2
- RBINHMBBHVXZON-UHFFFAOYSA-N 4-thiophen-2-ylpiperidine-4-carbonitrile Chemical compound C=1C=CSC=1C1(C#N)CCNCC1 RBINHMBBHVXZON-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- KMWIBRSMBSBRSC-HSZRJFAPSA-N 5-[2-[(3R)-3-(ethoxymethyl)-3-[2-(5-methylthiophen-2-yl)ethyl]pyrrolidin-1-yl]propan-2-yl]-2-methylpyridine Chemical compound CCOC[C@]1(CCc2ccc(C)s2)CCN(C1)C(C)(C)c1ccc(C)nc1 KMWIBRSMBSBRSC-HSZRJFAPSA-N 0.000 description 2
- DLVPCWMAXVEWAX-UHFFFAOYSA-N 5-[4-[[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]methyl]phenyl]-1,3,4-oxadiazol-2-amine Chemical compound C(C)OCC1(CCN(CC1)CC1=CC=C(C=C1)C1=NN=C(O1)N)CCC1=CC=CC=C1 DLVPCWMAXVEWAX-UHFFFAOYSA-N 0.000 description 2
- ODQJQEROUCVZNG-UHFFFAOYSA-N 5-fluoropyridine Chemical compound FC1=C=NC=C[CH]1 ODQJQEROUCVZNG-UHFFFAOYSA-N 0.000 description 2
- RRAYVESVMOMOEM-UHFFFAOYSA-N 7-methylpurine Chemical compound C1=NC=C2N(C)C=NC2=N1 RRAYVESVMOMOEM-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 2
- CKAPNPNLDLPKMH-ZDUSSCGKSA-N C(C)OC[C@@]1(CN(CC1)C(=O)OC(C)(C)C)C=O Chemical compound C(C)OC[C@@]1(CN(CC1)C(=O)OC(C)(C)C)C=O CKAPNPNLDLPKMH-ZDUSSCGKSA-N 0.000 description 2
- ZIBMDRSLLCVTFG-UHFFFAOYSA-N COC=CC1(CCN(CC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 Chemical compound COC=CC1(CCN(CC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 ZIBMDRSLLCVTFG-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 241001649081 Dina Species 0.000 description 2
- YZCKVEUIGOORGS-UHFFFAOYSA-N Hydrogen atom Chemical class [H] YZCKVEUIGOORGS-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 2
- XQAGVDNQKFLMAH-UHFFFAOYSA-N N-[4-[2-[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]ethyl]phenyl]acetamide Chemical compound C(C)OCC1(CCN(CC1)CCC1=CC=C(C=C1)NC(C)=O)CCC1=CC=CC=C1 XQAGVDNQKFLMAH-UHFFFAOYSA-N 0.000 description 2
- YKADCMBYOSIQFV-UHFFFAOYSA-N N-[4-[[3-(ethoxymethyl)-3-(2-phenylethyl)pyrrolidin-1-yl]methyl]phenyl]acetamide Chemical compound C(C)OCC1(CN(CC1)CC1=CC=C(C=C1)NC(C)=O)CCC1=CC=CC=C1 YKADCMBYOSIQFV-UHFFFAOYSA-N 0.000 description 2
- HUUUYUUKAYXYOG-UHFFFAOYSA-N N-[4-[[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]methyl]phenyl]-2,2,2-trifluoroacetamide Chemical compound C(C)OCC1(CCN(CC1)CC1=CC=C(C=C1)NC(C(F)(F)F)=O)CCC1=CC=CC=C1 HUUUYUUKAYXYOG-UHFFFAOYSA-N 0.000 description 2
- DPMZOUKUFNUBQP-UHFFFAOYSA-N N-[4-[[4-(oxetan-2-yl)-4-(2-phenylethyl)piperidin-1-yl]methyl]phenyl]acetamide Chemical compound O1C(CC1)C1(CCN(CC1)CC1=CC=C(C=C1)NC(C)=O)CCC1=CC=CC=C1 DPMZOUKUFNUBQP-UHFFFAOYSA-N 0.000 description 2
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 2
- XGEGHDBEHXKFPX-UHFFFAOYSA-N N-methylthiourea Natural products CNC(N)=O XGEGHDBEHXKFPX-UHFFFAOYSA-N 0.000 description 2
- NSHRXNHRCXGXAY-OUKQBFOZSA-N N1=C(C=CC=C1)C1(CCN(CC1)C(=O)OC(C)(C)C)\C=C\C1=CC=CC=C1 Chemical compound N1=C(C=CC=C1)C1(CCN(CC1)C(=O)OC(C)(C)C)\C=C\C1=CC=CC=C1 NSHRXNHRCXGXAY-OUKQBFOZSA-N 0.000 description 2
- 101100030361 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pph-3 gene Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- NYXAQEPQBRTGEX-JOCHJYFZSA-N [(3R)-3-(ethoxymethyl)-3-(2-phenylethyl)pyrrolidin-1-yl]-(6-methylpyridin-3-yl)methanone Chemical compound C(C)OC[C@]1(CN(CC1)C(=O)C=1C=NC(=CC=1)C)CCC1=CC=CC=C1 NYXAQEPQBRTGEX-JOCHJYFZSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000000304 alkynyl group Chemical group 0.000 description 2
- 125000005336 allyloxy group Chemical group 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- FMZMOLLKJFXCNK-UHFFFAOYSA-N azetidine-1,3-dicarboxylic acid Chemical compound OC(=O)C1CN(C(O)=O)C1 FMZMOLLKJFXCNK-UHFFFAOYSA-N 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 230000008033 biological extinction Effects 0.000 description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 2
- 239000004327 boric acid Substances 0.000 description 2
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 150000001721 carbon Chemical group 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 150000001735 carboxylic acids Chemical class 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 238000004296 chiral HPLC Methods 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- WDAXFOBOLVPGLV-UHFFFAOYSA-N ethyl isobutyrate Chemical compound CCOC(=O)C(C)C WDAXFOBOLVPGLV-UHFFFAOYSA-N 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 125000003037 imidazol-2-yl group Chemical group [H]N1C([*])=NC([H])=C1[H] 0.000 description 2
- JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical compound C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229940047889 isobutyramide Drugs 0.000 description 2
- 102000048260 kappa Opioid Receptors Human genes 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 2
- 229960005181 morphine Drugs 0.000 description 2
- 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 2
- 102000051367 mu Opioid Receptors Human genes 0.000 description 2
- 239000007922 nasal spray Substances 0.000 description 2
- 229940097496 nasal spray Drugs 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- 208000021722 neuropathic pain Diseases 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 2
- 229940127240 opiate Drugs 0.000 description 2
- 239000007800 oxidant agent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 150000002926 oxygen Chemical class 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 2
- 229940080818 propionamide Drugs 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- JAEIBKXSIXOLOL-UHFFFAOYSA-N pyrrolidin-1-ium-3-carboxylate Chemical compound OC(=O)C1CCNC1 JAEIBKXSIXOLOL-UHFFFAOYSA-N 0.000 description 2
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 125000006413 ring segment Chemical group 0.000 description 2
- 239000012047 saturated solution Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 2
- 235000019345 sodium thiosulphate Nutrition 0.000 description 2
- 238000013222 sprague-dawley male rat Methods 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 125000003107 substituted aryl group Chemical group 0.000 description 2
- 239000011593 sulfur Chemical group 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- ROEMZCLHRRRKGF-YUMQZZPRSA-N tert-butyl (2s,4s)-4-fluoro-2-(hydroxymethyl)pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1C[C@@H](F)C[C@H]1CO ROEMZCLHRRRKGF-YUMQZZPRSA-N 0.000 description 2
- FDOOARZIBHLEJB-UHFFFAOYSA-N tert-butyl 3-(1,3-dihydroxy-2,2-dimethylpropyl)-3-(2-phenylethyl)pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(CCc2ccccc2)(C1)C(O)C(C)(C)CO FDOOARZIBHLEJB-UHFFFAOYSA-N 0.000 description 2
- PPAOBOPURLKJES-UHFFFAOYSA-N tert-butyl 3-(ethoxymethyl)-3-(2-phenylethyl)pyrrolidine-1-carboxylate Chemical compound C(C)OCC1(CN(CC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 PPAOBOPURLKJES-UHFFFAOYSA-N 0.000 description 2
- WLUWOVPLXWDQIJ-UHFFFAOYSA-N tert-butyl 4-(1H-imidazol-2-yl)-4-(2-phenylethyl)piperidine-1-carboxylate Chemical compound N1C(=NC=C1)C1(CCN(CC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 WLUWOVPLXWDQIJ-UHFFFAOYSA-N 0.000 description 2
- GXWJITSWVXASGH-UHFFFAOYSA-N tert-butyl 4-(2-methoxyethyl)-4-(2-phenylethyl)piperidine-1-carboxylate Chemical compound COCCC1(CCN(CC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 GXWJITSWVXASGH-UHFFFAOYSA-N 0.000 description 2
- WHKIMUXDSAMLQE-UHFFFAOYSA-N tert-butyl 4-(difluoromethoxymethyl)-4-(2-phenylethyl)piperidine-1-carboxylate Chemical compound FC(OCC1(CCN(CC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1)F WHKIMUXDSAMLQE-UHFFFAOYSA-N 0.000 description 2
- SUSIPTVRQQCXSS-UHFFFAOYSA-N tert-butyl 4-(hydroxymethyl)-4-(2-phenylethyl)piperidine-1-carboxylate Chemical compound OCC1(CCN(CC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 SUSIPTVRQQCXSS-UHFFFAOYSA-N 0.000 description 2
- LZYYYNSPONGZSE-UHFFFAOYSA-N tert-butyl 4-[(E)-N'-hydroxycarbamimidoyl]-4-(2-phenylethyl)piperidine-1-carboxylate Chemical compound ON=C(N)C1(CCN(CC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 LZYYYNSPONGZSE-UHFFFAOYSA-N 0.000 description 2
- VQXIHNKWSXYBDC-UHFFFAOYSA-N tert-butyl 4-[(dimethylamino)methyl]-4-(2-phenylethyl)piperidine-1-carboxylate Chemical compound CN(C)CC1(CCN(CC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 VQXIHNKWSXYBDC-UHFFFAOYSA-N 0.000 description 2
- SGNKPJPMWHKOJO-UHFFFAOYSA-N tert-butyl n-[4-(hydroxymethyl)cyclohexyl]carbamate Chemical compound CC(C)(C)OC(=O)NC1CCC(CO)CC1 SGNKPJPMWHKOJO-UHFFFAOYSA-N 0.000 description 2
- DNSTUAQHBFISRZ-UHFFFAOYSA-N tert-butyl n-cyclohexylcarbamate Chemical compound CC(C)(C)OC(=O)NC1CCCCC1 DNSTUAQHBFISRZ-UHFFFAOYSA-N 0.000 description 2
- LPQZERIRKRYGGM-UHFFFAOYSA-N tert-butyl pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCC1 LPQZERIRKRYGGM-UHFFFAOYSA-N 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- CMSYDJVRTHCWFP-UHFFFAOYSA-N triphenylphosphane;hydrobromide Chemical compound Br.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 CMSYDJVRTHCWFP-UHFFFAOYSA-N 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- JPTFTXJFZCEUNP-CRAIPNDOSA-N (1R)-1-[(3R)-1-(pyridin-3-ylmethyl)-3-(2-thiophen-2-ylethyl)pyrrolidin-3-yl]ethanol Chemical compound C[C@@H](O)[C@]1(CCc2cccs2)CCN(Cc2cccnc2)C1 JPTFTXJFZCEUNP-CRAIPNDOSA-N 0.000 description 1
- RQEUFEKYXDPUSK-SSDOTTSWSA-N (1R)-1-phenylethanamine Chemical compound C[C@@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-SSDOTTSWSA-N 0.000 description 1
- JPTFTXJFZCEUNP-MAUKXSAKSA-N (1S)-1-[(3R)-1-(pyridin-3-ylmethyl)-3-(2-thiophen-2-ylethyl)pyrrolidin-3-yl]ethanol Chemical compound C[C@H](O)[C@]1(CCc2cccs2)CCN(Cc2cccnc2)C1 JPTFTXJFZCEUNP-MAUKXSAKSA-N 0.000 description 1
- RQEUFEKYXDPUSK-ZETCQYMHSA-N (1S)-1-phenylethanamine Chemical compound C[C@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-ZETCQYMHSA-N 0.000 description 1
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 1
- ZEVLANFVOPBZQE-CQSZACIVSA-N (3R)-3-(ethoxymethyl)-3-[2-(5-methylthiophen-3-yl)ethyl]pyrrolidine Chemical compound C(C)OC[C@]1(CNCC1)CCC1=CSC(=C1)C ZEVLANFVOPBZQE-CQSZACIVSA-N 0.000 description 1
- YBUPWRYTXGAWJX-RXMQYKEDSA-N (4s)-4-propan-2-yl-1,3-oxazolidin-2-one Chemical compound CC(C)[C@H]1COC(=O)N1 YBUPWRYTXGAWJX-RXMQYKEDSA-N 0.000 description 1
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 description 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 description 1
- 125000001766 1,2,4-oxadiazol-3-yl group Chemical group [H]C1=NC(*)=NO1 0.000 description 1
- 125000004509 1,3,4-oxadiazol-2-yl group Chemical group O1C(=NN=C1)* 0.000 description 1
- FKASFBLJDCHBNZ-UHFFFAOYSA-N 1,3,4-oxadiazole Chemical compound C1=NN=CO1 FKASFBLJDCHBNZ-UHFFFAOYSA-N 0.000 description 1
- 125000004521 1,3,4-thiadiazol-2-yl group Chemical group S1C(=NN=C1)* 0.000 description 1
- 125000000196 1,4-pentadienyl group Chemical group [H]C([*])=C([H])C([H])([H])C([H])=C([H])[H] 0.000 description 1
- MOHYOXXOKFQHDC-UHFFFAOYSA-N 1-(chloromethyl)-4-methoxybenzene Chemical compound COC1=CC=C(CCl)C=C1 MOHYOXXOKFQHDC-UHFFFAOYSA-N 0.000 description 1
- BJESJGOTMMGXJR-UHFFFAOYSA-N 1-(oxan-2-yl)pyrrolidine Chemical compound C1CCCN1C1OCCCC1 BJESJGOTMMGXJR-UHFFFAOYSA-N 0.000 description 1
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide Substances CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- GQDGFTADINTKDC-ZHACJKMWSA-N 1-O-tert-butyl 3-O-methyl 3-[(E)-2-phenylethenyl]azetidine-1,3-dicarboxylate Chemical compound COC(=O)C1(CN(C1)C(=O)OC(C)(C)C)\C=C\c1ccccc1 GQDGFTADINTKDC-ZHACJKMWSA-N 0.000 description 1
- TVQCPLBZIHVISZ-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]-3-(oxan-2-yl)-3-(2-phenylethyl)pyrrolidine Chemical compound Clc1ccccc1CN1CCC(CCc2ccccc2)(C1)C1CCCCO1 TVQCPLBZIHVISZ-UHFFFAOYSA-N 0.000 description 1
- CGRVWTWZZBRMEI-UHFFFAOYSA-N 1-[(4-acetamidophenyl)methyl]-N-methyl-4-(2-phenylethyl)piperidine-4-carboxamide Chemical compound CNC(=O)C1(CCc2ccccc2)CCN(Cc2ccc(NC(C)=O)cc2)CC1 CGRVWTWZZBRMEI-UHFFFAOYSA-N 0.000 description 1
- RXZQAKOCWRJVHK-UHFFFAOYSA-N 1-[(4-bromophenyl)methyl]-3-(ethoxymethyl)-3-(2-phenylethyl)pyrrolidine Chemical compound CCOCC1(CCC2=CC=CC=C2)CCN(CC2=CC=C(Br)C=C2)C1 RXZQAKOCWRJVHK-UHFFFAOYSA-N 0.000 description 1
- AHZFISVKQUPMBW-UHFFFAOYSA-N 1-[(4-bromophenyl)methyl]-4-(ethoxymethyl)-4-(2-phenylethyl)piperidine Chemical compound CCOCC1(CCc2ccccc2)CCN(Cc2ccc(Br)cc2)CC1 AHZFISVKQUPMBW-UHFFFAOYSA-N 0.000 description 1
- WFQDTOYDVUWQMS-UHFFFAOYSA-N 1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1 WFQDTOYDVUWQMS-UHFFFAOYSA-N 0.000 description 1
- CMSVKEVOBXPEHI-UHFFFAOYSA-N 1-hydroxy-2-methylguanidine Chemical compound CN=C(N)NO CMSVKEVOBXPEHI-UHFFFAOYSA-N 0.000 description 1
- MYFZXSOYJVWTBL-UHFFFAOYSA-N 1-methylpyrazole-4-carbaldehyde Chemical compound CN1C=C(C=O)C=N1 MYFZXSOYJVWTBL-UHFFFAOYSA-N 0.000 description 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 description 1
- SECFRXGVLMVUPD-UHFFFAOYSA-N 1-o-tert-butyl 3-o-methyl azetidine-1,3-dicarboxylate Chemical compound COC(=O)C1CN(C(=O)OC(C)(C)C)C1 SECFRXGVLMVUPD-UHFFFAOYSA-N 0.000 description 1
- BGPXTFAKEGFVAZ-UHFFFAOYSA-N 1-o-tert-butyl 4-o-ethyl 4-(2-phenylethyl)piperidine-1,4-dicarboxylate Chemical compound C=1C=CC=CC=1CCC1(C(=O)OCC)CCN(C(=O)OC(C)(C)C)CC1 BGPXTFAKEGFVAZ-UHFFFAOYSA-N 0.000 description 1
- WITMXBRCQWOZPX-UHFFFAOYSA-N 1-phenylpyrazole Chemical compound C1=CC=NN1C1=CC=CC=C1 WITMXBRCQWOZPX-UHFFFAOYSA-N 0.000 description 1
- QMDUEBURHKSKDG-UHFFFAOYSA-N 1-pyridin-3-ylethanol Chemical compound CC(O)C1=CC=CN=C1 QMDUEBURHKSKDG-UHFFFAOYSA-N 0.000 description 1
- 125000001462 1-pyrrolyl group Chemical group [*]N1C([H])=C([H])C([H])=C1[H] 0.000 description 1
- APXRHPDHORGIEB-UHFFFAOYSA-N 1H-pyrazolo[4,3-d]pyrimidine Chemical compound N1=CN=C2C=NNC2=C1 APXRHPDHORGIEB-UHFFFAOYSA-N 0.000 description 1
- DNCYBUMDUBHIJZ-UHFFFAOYSA-N 1h-pyrimidin-6-one Chemical compound O=C1C=CN=CN1 DNCYBUMDUBHIJZ-UHFFFAOYSA-N 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- VYDQUABHDFWIIX-UHFFFAOYSA-N 2,2-difluoro-2-fluorosulfonylacetic acid Chemical compound OC(=O)C(F)(F)S(F)(=O)=O VYDQUABHDFWIIX-UHFFFAOYSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- PTLWKRLAWHBMLM-UHFFFAOYSA-N 2,3-dihydroazete Chemical compound C1CN=C1 PTLWKRLAWHBMLM-UHFFFAOYSA-N 0.000 description 1
- WVIQPBIZBQRJAD-UHFFFAOYSA-N 2,5-dimethylthiophene-3-carbaldehyde Chemical compound CC1=CC(C=O)=C(C)S1 WVIQPBIZBQRJAD-UHFFFAOYSA-N 0.000 description 1
- OESMBUMMTXSJRB-UHFFFAOYSA-N 2-(2,2,2-trifluoroethyl)aniline Chemical compound NC1=CC=CC=C1CC(F)(F)F OESMBUMMTXSJRB-UHFFFAOYSA-N 0.000 description 1
- SCCSIUUMCRHMFR-UHFFFAOYSA-N 2-[1-(pyridin-3-ylmethyl)-3-(2-thiophen-2-ylethyl)pyrrolidin-3-yl]pyridine Chemical compound C(CC1(CCN(Cc2cccnc2)C1)c1ccccn1)c1cccs1 SCCSIUUMCRHMFR-UHFFFAOYSA-N 0.000 description 1
- SSDQFSXIWQUCJX-UHFFFAOYSA-N 2-[1-benzyl-4-(2-phenylethyl)piperidin-4-yl]pyridine Chemical compound C(CC1(CCN(Cc2ccccc2)CC1)c1ccccn1)c1ccccc1 SSDQFSXIWQUCJX-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- USALUCYDVLKKPQ-UXCHGGSFSA-N 2-[2-[(2R,6S)-2,6-dimethyl-1-[2-(6-methylpyridin-3-yl)propan-2-yl]-4-pyridin-2-ylpiperidin-4-yl]ethyl]-5-fluoropyridine Chemical compound C[C@H]1CC(CCc2ccc(F)cn2)(C[C@@H](C)N1C(C)(C)c1ccc(C)nc1)c1ccccn1 USALUCYDVLKKPQ-UXCHGGSFSA-N 0.000 description 1
- USALUCYDVLKKPQ-VXKWHMMOSA-N 2-[2-[(2S,6S)-2,6-dimethyl-1-[2-(6-methylpyridin-3-yl)propan-2-yl]-4-pyridin-2-ylpiperidin-4-yl]ethyl]-5-fluoropyridine Chemical compound C[C@H]1CC(CCc2ccc(F)cn2)(C[C@H](C)N1C(C)(C)c1ccc(C)nc1)c1ccccn1 USALUCYDVLKKPQ-VXKWHMMOSA-N 0.000 description 1
- OEDJNURUACNRMW-HXUWFJFHSA-N 2-[2-[(3R)-3-(ethoxymethyl)-1-(pyridin-3-ylmethyl)pyrrolidin-3-yl]ethyl]-5-fluoropyridine Chemical compound CCOC[C@]1(CCc2ccc(F)cn2)CCN(Cc2cccnc2)C1 OEDJNURUACNRMW-HXUWFJFHSA-N 0.000 description 1
- SWNLVCIRDPDZOL-HXUWFJFHSA-N 2-[2-[(3R)-3-(ethoxymethyl)-1-(pyridin-3-ylmethyl)pyrrolidin-3-yl]ethyl]pyridine Chemical compound CCOC[C@]1(CCc2ccccn2)CCN(Cc2cccnc2)C1 SWNLVCIRDPDZOL-HXUWFJFHSA-N 0.000 description 1
- XBNPBOGLFALHOT-UHFFFAOYSA-N 2-[4-(2-phenylethyl)piperidin-4-yl]-1,3,4-oxadiazole Chemical compound C(CC1(CCNCC1)C1=NN=CO1)C1=CC=CC=C1 XBNPBOGLFALHOT-UHFFFAOYSA-N 0.000 description 1
- HFQYTJXDKUHWLG-UHFFFAOYSA-N 2-[4-(2-phenylethyl)piperidin-4-yl]pyridine Chemical compound C1(=CC=CC=C1)CCC1(CCNCC1)C1=NC=CC=C1 HFQYTJXDKUHWLG-UHFFFAOYSA-N 0.000 description 1
- 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 1
- RXNZFHIEDZEUQM-UHFFFAOYSA-N 2-bromo-1,3-thiazole Chemical compound BrC1=NC=CS1 RXNZFHIEDZEUQM-UHFFFAOYSA-N 0.000 description 1
- TUCRZHGAIRVWTI-UHFFFAOYSA-N 2-bromothiophene Chemical compound BrC1=CC=CS1 TUCRZHGAIRVWTI-UHFFFAOYSA-N 0.000 description 1
- 125000006282 2-chlorobenzyl group Chemical group [H]C1=C([H])C(Cl)=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- DPGSPRJLAZGUBQ-UHFFFAOYSA-N 2-ethenyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound CC1(C)OB(C=C)OC1(C)C DPGSPRJLAZGUBQ-UHFFFAOYSA-N 0.000 description 1
- MTAODLNXWYIKSO-UHFFFAOYSA-N 2-fluoropyridine Chemical compound FC1=CC=CC=N1 MTAODLNXWYIKSO-UHFFFAOYSA-N 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- KVTHPKXDLVYNCH-UHFFFAOYSA-N 2-iodoethylbenzene Chemical compound ICCC1=CC=CC=C1 KVTHPKXDLVYNCH-UHFFFAOYSA-N 0.000 description 1
- IWTFOFMTUOBLHG-UHFFFAOYSA-N 2-methoxypyridine Chemical compound COC1=CC=CC=N1 IWTFOFMTUOBLHG-UHFFFAOYSA-N 0.000 description 1
- XKXKPOGKKBXWMV-FYYLOGMGSA-N 2-methyl-5-[2-[(3R)-3-[(2R)-oxolan-2-yl]-3-(2-thiophen-2-ylethyl)pyrrolidin-1-yl]propan-2-yl]pyridine Chemical compound Cc1ccc(cn1)C(C)(C)N1CC[C@](CCc2cccs2)(C1)[C@H]1CCCO1 XKXKPOGKKBXWMV-FYYLOGMGSA-N 0.000 description 1
- LRWXVWLRTCTHMM-UHFFFAOYSA-N 2-methyl-5-[[4-(2-phenylethyl)-4-pyridin-2-ylpiperidin-1-yl]methyl]pyridine Chemical compound Cc1ccc(CN2CCC(CCc3ccccc3)(CC2)c2ccccn2)cn1 LRWXVWLRTCTHMM-UHFFFAOYSA-N 0.000 description 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 description 1
- FZIPCQLKPTZZIM-UHFFFAOYSA-N 2-oxidanylpropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FZIPCQLKPTZZIM-UHFFFAOYSA-N 0.000 description 1
- MUAUTBNKPSNTFM-UHFFFAOYSA-N 2-phenylethyl carbamate Chemical compound NC(=O)OCCC1=CC=CC=C1 MUAUTBNKPSNTFM-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- FJDCAVVJWLFCKE-UHFFFAOYSA-N 3-(oxan-2-yl)-3-(2-phenylethyl)-1-[(2-thiophen-2-ylphenyl)methyl]pyrrolidine Chemical compound C(CC1(CCN(Cc2ccccc2-c2cccs2)C1)C1CCCCO1)c1ccccc1 FJDCAVVJWLFCKE-UHFFFAOYSA-N 0.000 description 1
- DRZVJYVNJDRDRO-JOCHJYFZSA-N 3-[[(3R)-3-(ethoxymethyl)-3-(2-thiophen-2-ylethyl)pyrrolidin-1-yl]methyl]-2,4,6-trimethylpyridine Chemical compound CCOC[C@]1(CCc2cccs2)CCN(Cc2c(C)cc(C)nc2C)C1 DRZVJYVNJDRDRO-JOCHJYFZSA-N 0.000 description 1
- MBEZMQYZDQLWDV-OAQYLSRUSA-N 3-[[(3R)-3-(ethoxymethyl)-3-(2-thiophen-2-ylethyl)pyrrolidin-1-yl]methyl]-2,4-dimethylpyridine Chemical compound CCOC[C@]1(CCc2cccs2)CCN(Cc2c(C)ccnc2C)C1 MBEZMQYZDQLWDV-OAQYLSRUSA-N 0.000 description 1
- LZDIJTJXHRTJMA-HXUWFJFHSA-N 3-[[(3R)-3-(ethoxymethyl)-3-(2-thiophen-2-ylethyl)pyrrolidin-1-yl]methyl]-2-methylpyridine Chemical compound CCOC[C@]1(CCc2cccs2)CCN(Cc2cccnc2C)C1 LZDIJTJXHRTJMA-HXUWFJFHSA-N 0.000 description 1
- QWEXGIAODFASSM-GOSISDBHSA-N 3-[[(3R)-3-(ethoxymethyl)-3-(2-thiophen-2-ylethyl)pyrrolidin-1-yl]methyl]pyridazine Chemical compound CCOC[C@]1(CCc2cccs2)CCN(Cc2cccnn2)C1 QWEXGIAODFASSM-GOSISDBHSA-N 0.000 description 1
- MIGINBPJZKQZHC-HXUWFJFHSA-N 3-[[(3R)-3-(ethoxymethyl)-3-[2-(3-methylthiophen-2-yl)ethyl]pyrrolidin-1-yl]methyl]pyridine Chemical compound CCOC[C@]1(CCc2sccc2C)CCN(Cc2cccnc2)C1 MIGINBPJZKQZHC-HXUWFJFHSA-N 0.000 description 1
- MYGFACCLQFCZND-HXUWFJFHSA-N 3-[[(3R)-3-(ethoxymethyl)-3-[2-(4-methylthiophen-2-yl)ethyl]pyrrolidin-1-yl]methyl]pyridine Chemical compound CCOC[C@]1(CCc2cc(C)cs2)CCN(Cc2cccnc2)C1 MYGFACCLQFCZND-HXUWFJFHSA-N 0.000 description 1
- UVYPAHPKXKQZHW-HXUWFJFHSA-N 3-[[(3R)-3-(ethoxymethyl)-3-[2-(5-methylthiophen-3-yl)ethyl]pyrrolidin-1-yl]methyl]pyridine Chemical compound C(C)OC[C@]1(CN(CC1)CC=1C=NC=CC=1)CCC1=CSC(=C1)C UVYPAHPKXKQZHW-HXUWFJFHSA-N 0.000 description 1
- ARESPZMNNBEGFJ-OAQYLSRUSA-N 3-[[(3R)-3-[2-(2-chlorophenyl)ethyl]-3-(ethoxymethyl)pyrrolidin-1-yl]methyl]pyridine Chemical compound CCOC[C@]1(CCc2ccccc2Cl)CCN(Cc2cccnc2)C1 ARESPZMNNBEGFJ-OAQYLSRUSA-N 0.000 description 1
- YUBIDIKISQFUCW-OAQYLSRUSA-N 3-[[(3R)-3-[2-(3-chlorophenyl)ethyl]-3-(ethoxymethyl)pyrrolidin-1-yl]methyl]pyridine Chemical compound CCOC[C@]1(CCc2cccc(Cl)c2)CCN(Cc2cccnc2)C1 YUBIDIKISQFUCW-OAQYLSRUSA-N 0.000 description 1
- FGGPWFSTSXZUDG-OAQYLSRUSA-N 3-[[(3R)-3-[2-(4-chlorophenyl)ethyl]-3-(ethoxymethyl)pyrrolidin-1-yl]methyl]pyridine Chemical compound CCOC[C@]1(CCc2ccc(Cl)cc2)CCN(Cc2cccnc2)C1 FGGPWFSTSXZUDG-OAQYLSRUSA-N 0.000 description 1
- JZAYQOVTXMJFBF-UHFFFAOYSA-N 3-[[3-(2,5-dihydrofuran-2-yl)-3-(2-thiophen-3-ylethyl)pyrrolidin-1-yl]methyl]pyridine Chemical compound C(CC1(CCN(Cc2cccnc2)C1)C1OCC=C1)c1ccsc1 JZAYQOVTXMJFBF-UHFFFAOYSA-N 0.000 description 1
- MIGINBPJZKQZHC-UHFFFAOYSA-N 3-[[3-(ethoxymethyl)-3-[2-(3-methylthiophen-2-yl)ethyl]pyrrolidin-1-yl]methyl]pyridine Chemical compound CCOCC1(CCc2sccc2C)CCN(Cc2cccnc2)C1 MIGINBPJZKQZHC-UHFFFAOYSA-N 0.000 description 1
- CUYKNJBYIJFRCU-UHFFFAOYSA-N 3-aminopyridine Chemical compound NC1=CC=CN=C1 CUYKNJBYIJFRCU-UHFFFAOYSA-N 0.000 description 1
- 125000004975 3-butenyl group Chemical group C(CC=C)* 0.000 description 1
- 125000000474 3-butynyl group Chemical group [H]C#CC([H])([H])C([H])([H])* 0.000 description 1
- XLTMSDCEBVIIGC-UHFFFAOYSA-N 3-chloro-5-[[3-(oxolan-2-yl)-3-(2-phenylethyl)pyrrolidin-1-yl]methyl]pyridine Chemical compound Clc1cncc(CN2CCC(CCc3ccccc3)(C2)C2CCCO2)c1 XLTMSDCEBVIIGC-UHFFFAOYSA-N 0.000 description 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- KYINPWAJIVTFBW-UHFFFAOYSA-N 3-methylpyrrolidine Chemical compound CC1CCNC1 KYINPWAJIVTFBW-UHFFFAOYSA-N 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- BAJINOFLJMNYNI-UHFFFAOYSA-N 4-(1H-imidazol-2-yl)-4-(2-phenylethyl)piperidine Chemical compound N1C(=NC=C1)C1(CCNCC1)CCC1=CC=CC=C1 BAJINOFLJMNYNI-UHFFFAOYSA-N 0.000 description 1
- ZIRVEAYPUOXNEO-UHFFFAOYSA-N 4-(2-methoxyethyl)-4-(2-phenylethyl)piperidine Chemical compound COCCC1(CCNCC1)CCC1=CC=CC=C1 ZIRVEAYPUOXNEO-UHFFFAOYSA-N 0.000 description 1
- HGYZGPDRWKZAEU-UHFFFAOYSA-N 4-(ethoxymethyl)-1-(4-nitrophenyl)-4-(2-phenylethyl)piperidine Chemical compound C(C)OCC1(CCN(CC1)C1=CC=C(C=C1)[N+](=O)[O-])CCC1=CC=CC=C1 HGYZGPDRWKZAEU-UHFFFAOYSA-N 0.000 description 1
- IVERMKIWIZRHAX-UHFFFAOYSA-N 4-(ethoxymethyl)-1-[(4-ethynylphenyl)methyl]-4-(2-phenylethyl)piperidine Chemical compound C(C)OCC1(CCN(CC1)CC1=CC=C(C=C1)C#C)CCC1=CC=CC=C1 IVERMKIWIZRHAX-UHFFFAOYSA-N 0.000 description 1
- IFYSCKLASPMBOF-UHFFFAOYSA-N 4-(ethoxymethyl)-1-[(4-nitrophenyl)methyl]-4-(2-phenylethyl)piperidine Chemical compound C(C)OCC1(CCN(CC1)CC1=CC=C(C=C1)[N+](=O)[O-])CCC1=CC=CC=C1 IFYSCKLASPMBOF-UHFFFAOYSA-N 0.000 description 1
- NHYGPNSJHWHBFJ-UHFFFAOYSA-N 4-(ethoxymethyl)-1-[[4-(2-methoxyethyl)phenyl]methyl]-4-(2-phenylethyl)piperidine Chemical compound CCOCC1(CCc2ccccc2)CCN(Cc2ccc(CCOC)cc2)CC1 NHYGPNSJHWHBFJ-UHFFFAOYSA-N 0.000 description 1
- XSUUWOWBIJPBPV-UHFFFAOYSA-N 4-(ethoxymethyl)-1-[[4-(methoxymethyl)phenyl]methyl]-4-(2-phenylethyl)piperidine Chemical compound CCOCC1(CCc2ccccc2)CCN(Cc2ccc(COC)cc2)CC1 XSUUWOWBIJPBPV-UHFFFAOYSA-N 0.000 description 1
- XNIJSJXNZOUQPC-UHFFFAOYSA-N 4-(ethoxymethyl)-1-methyl-4-(2-phenylethyl)piperidine Chemical compound CCOCC1(CCc2ccccc2)CCN(C)CC1 XNIJSJXNZOUQPC-UHFFFAOYSA-N 0.000 description 1
- VPHNCKXOLPBQTL-UHFFFAOYSA-N 4-(oxolan-2-yl)-4-(2-phenylethyl)piperidine Chemical compound C1(=CC=CC=C1)CCC1(CCNCC1)C1OCCC1 VPHNCKXOLPBQTL-UHFFFAOYSA-N 0.000 description 1
- NIWMFAYRWLXOGW-UHFFFAOYSA-N 4-[1-[3-(ethoxymethyl)-3-(2-phenylethyl)pyrrolidin-1-yl]ethyl]-1-methylpyrazole Chemical compound C(C)OCC1(CN(CC1)C(C)C=1C=NN(C=1)C)CCC1=CC=CC=C1 NIWMFAYRWLXOGW-UHFFFAOYSA-N 0.000 description 1
- VIWNMYDLJANSGF-UHFFFAOYSA-N 4-[2-(2,5-dimethylthiophen-3-yl)ethyl]-4-(ethoxymethyl)-1-[(1-methylpyrazol-4-yl)methyl]piperidine Chemical compound CC=1SC(=CC=1CCC1(CCN(CC1)CC=1C=NN(C=1)C)COCC)C VIWNMYDLJANSGF-UHFFFAOYSA-N 0.000 description 1
- LAUJGIUIXQFLCZ-GOSISDBHSA-N 4-[[(3R)-3-(ethoxymethyl)-3-(2-thiophen-2-ylethyl)pyrrolidin-1-yl]methyl]-1-methylpyrazole Chemical compound CCOC[C@]1(CCc2cccs2)CCN(Cc2cnn(C)c2)C1 LAUJGIUIXQFLCZ-GOSISDBHSA-N 0.000 description 1
- VGVITLHNIWJCRT-GOSISDBHSA-N 4-[[(3R)-3-(ethoxymethyl)-3-(2-thiophen-3-ylethyl)pyrrolidin-1-yl]methyl]-1-methylpyrazole Chemical compound CCOC[C@]1(CCc2ccsc2)CCN(Cc2cnn(C)c2)C1 VGVITLHNIWJCRT-GOSISDBHSA-N 0.000 description 1
- BGCIYQKZRTXGGE-UHFFFAOYSA-N 4-[[4-(2-phenylethyl)-4-pyridin-2-ylpiperidin-1-yl]methyl]aniline Chemical compound Nc1ccc(CN2CCC(CCc3ccccc3)(CC2)c2ccccn2)cc1 BGCIYQKZRTXGGE-UHFFFAOYSA-N 0.000 description 1
- YFWMYXOYCWHHBB-UHFFFAOYSA-N 4-[[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]methyl]benzoic acid Chemical compound C(C)OCC1(CCN(CC1)CC1=CC=C(C(=O)O)C=C1)CCC1=CC=CC=C1 YFWMYXOYCWHHBB-UHFFFAOYSA-N 0.000 description 1
- MSZCSIXESDENHA-UHFFFAOYSA-N 4-[[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]methyl]benzonitrile Chemical compound C(C)OCC1(CCN(CC1)CC1=CC=C(C#N)C=C1)CCC1=CC=CC=C1 MSZCSIXESDENHA-UHFFFAOYSA-N 0.000 description 1
- QCZHEPNUGLBURR-UHFFFAOYSA-N 4-[[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]methyl]cyclohexan-1-amine Chemical compound C(C)OCC1(CCN(CC1)CC1CCC(CC1)N)CCC1=CC=CC=C1 QCZHEPNUGLBURR-UHFFFAOYSA-N 0.000 description 1
- DRNGLYHKYPNTEA-UHFFFAOYSA-N 4-azaniumylcyclohexane-1-carboxylate Chemical compound NC1CCC(C(O)=O)CC1 DRNGLYHKYPNTEA-UHFFFAOYSA-N 0.000 description 1
- ABMUSXPGSSMPLK-UHFFFAOYSA-N 4-bromo-2-methylthiophene Chemical compound CC1=CC(Br)=CS1 ABMUSXPGSSMPLK-UHFFFAOYSA-N 0.000 description 1
- ZRYZBQLXDKPBDU-UHFFFAOYSA-N 4-bromobenzaldehyde Chemical compound BrC1=CC=C(C=O)C=C1 ZRYZBQLXDKPBDU-UHFFFAOYSA-N 0.000 description 1
- WIHHVKUARKTSBU-UHFFFAOYSA-N 4-bromobenzene-1,2-diamine Chemical compound NC1=CC=C(Br)C=C1N WIHHVKUARKTSBU-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- CASWWHJVYNKHDD-UHFFFAOYSA-N 4-ethoxycarbonyl-2,3,6,7-tetrahydroazepine-1-carboxylic acid Chemical compound CCOC(=O)C1=CCCN(CC1)C(O)=O CASWWHJVYNKHDD-UHFFFAOYSA-N 0.000 description 1
- PENVYHXKYYCYML-UHFFFAOYSA-N 4-methoxypyrimidine Chemical compound COC1=CC=NC=N1 PENVYHXKYYCYML-UHFFFAOYSA-N 0.000 description 1
- BXRFQSNOROATLV-UHFFFAOYSA-N 4-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=C(C=O)C=C1 BXRFQSNOROATLV-UHFFFAOYSA-N 0.000 description 1
- KDDQRKBRJSGMQE-UHFFFAOYSA-N 4-thiazolyl Chemical group [C]1=CSC=N1 KDDQRKBRJSGMQE-UHFFFAOYSA-N 0.000 description 1
- QMHIMXFNBOYPND-UHFFFAOYSA-N 4MTO Natural products CC1=CSC=N1 QMHIMXFNBOYPND-UHFFFAOYSA-N 0.000 description 1
- CTSXHEZAQDXERR-OAQYLSRUSA-N 5-[1-[(3R)-3-(ethoxymethyl)-3-(2-thiophen-2-ylethyl)pyrrolidin-1-yl]cyclopropyl]-2-methylpyridine Chemical compound C(C)OC[C@]1(CN(CC1)C1(CC1)C=1C=CC(=NC=1)C)CCC=1SC=CC=1 CTSXHEZAQDXERR-OAQYLSRUSA-N 0.000 description 1
- ZDCIQBLEHXRZSU-BDPMCISCSA-N 5-[1-[(3R)-3-(ethoxymethyl)-3-[2-(1-methylimidazol-2-yl)ethyl]pyrrolidin-1-yl]ethyl]-2-methylpyridine Chemical compound CCOC[C@]1(CCc2nccn2C)CCN(C1)C(C)c1ccc(C)nc1 ZDCIQBLEHXRZSU-BDPMCISCSA-N 0.000 description 1
- DTGSPSCZMSTCOD-HXUWFJFHSA-N 5-[1-[(3S)-3-(ethoxymethyl)-3-(2-imidazol-1-ylethyl)pyrrolidin-1-yl]cyclopropyl]-2-methylpyridine Chemical compound CCOC[C@]1(CCn2ccnc2)CCN(C1)C1(CC1)c1ccc(C)nc1 DTGSPSCZMSTCOD-HXUWFJFHSA-N 0.000 description 1
- DCGPTQXQLSXCKC-UHFFFAOYSA-N 5-[1-[3-(ethoxymethyl)-3-(2-pyridin-2-ylethyl)pyrrolidin-1-yl]ethyl]-2-methylpyridine Chemical compound CCOCC1(CCc2ccccn2)CCN(C1)C(C)c1ccc(C)nc1 DCGPTQXQLSXCKC-UHFFFAOYSA-N 0.000 description 1
- HWWGHUFPGATTES-UHFFFAOYSA-N 5-[1-[3-(ethoxymethyl)-3-(2-pyridin-3-ylethyl)pyrrolidin-1-yl]ethyl]-2-methylpyridine Chemical compound CCOCC1(CCc2cccnc2)CCN(C1)C(C)c1ccc(C)nc1 HWWGHUFPGATTES-UHFFFAOYSA-N 0.000 description 1
- YYHUWRGBMRFBLZ-UHFFFAOYSA-N 5-[1-[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]cyclohexyl]-2-methylpyridine Chemical compound C(C)OCC1(CCN(CC1)C1(CCCCC1)C=1C=CC(=NC=1)C)CCC1=CC=CC=C1 YYHUWRGBMRFBLZ-UHFFFAOYSA-N 0.000 description 1
- HEXYHAAKKAMQLN-ZMBIFBSDSA-N 5-[2-[(3R)-3-(2-cyclopropylethyl)-3-(ethoxymethyl)pyrrolidin-1-yl]propan-2-yl]-2-methylpyridine 2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(CC(O)=O)C(O)=O.CCOC[C@]1(CCC2CC2)CCN(C1)C(C)(C)c1ccc(C)nc1 HEXYHAAKKAMQLN-ZMBIFBSDSA-N 0.000 description 1
- YNLHPOOCXDPUPX-XMMPIXPASA-N 5-[2-[(3R)-3-(2-ethoxypropan-2-yl)-3-(2-thiophen-2-ylethyl)pyrrolidin-1-yl]propan-2-yl]-2-methylpyridine Chemical compound CCOC(C)(C)[C@]1(CCc2cccs2)CCN(C1)C(C)(C)c1ccc(C)nc1 YNLHPOOCXDPUPX-XMMPIXPASA-N 0.000 description 1
- HMDJCQHYAAGWTB-HSZRJFAPSA-N 5-[2-[(3R)-3-(ethoxymethyl)-3-(2-pyridin-2-ylethyl)pyrrolidin-1-yl]propan-2-yl]-2-methylpyridine Chemical compound CCOC[C@]1(CCc2ccccn2)CCN(C1)C(C)(C)c1ccc(C)nc1 HMDJCQHYAAGWTB-HSZRJFAPSA-N 0.000 description 1
- BPARUENSGLQIAG-JOCHJYFZSA-N 5-[2-[(3R)-3-(ethoxymethyl)-3-(2-thiophen-2-ylethyl)pyrrolidin-1-yl]propan-2-yl]-2-methylpyridine Chemical compound CCOC[C@]1(CCc2cccs2)CCN(C1)C(C)(C)c1ccc(C)nc1 BPARUENSGLQIAG-JOCHJYFZSA-N 0.000 description 1
- DGHPMWJWZDNRSX-XMMPIXPASA-N 5-[2-[(3R)-3-(ethoxymethyl)-3-(phenylmethoxymethyl)pyrrolidin-1-yl]propan-2-yl]-2-methylpyridine Chemical compound CCOC[C@@]1(COCc2ccccc2)CCN(C1)C(C)(C)c1ccc(C)nc1 DGHPMWJWZDNRSX-XMMPIXPASA-N 0.000 description 1
- COCNGNGMEQSIOS-HSZRJFAPSA-N 5-[2-[(3R)-3-(ethoxymethyl)-3-[2-(4-methylthiophen-2-yl)ethyl]pyrrolidin-1-yl]propan-2-yl]-2-methylpyridine Chemical compound CCOC[C@]1(CCc2cc(C)cs2)CCN(C1)C(C)(C)c1ccc(C)nc1 COCNGNGMEQSIOS-HSZRJFAPSA-N 0.000 description 1
- PDZAPTRDWNCSMQ-UHFFFAOYSA-N 5-[2-[3-(2-cyclopropylethyl)-3-(ethoxymethyl)pyrrolidin-1-yl]propan-2-yl]-2-methylpyridine Chemical compound CCOCC1(CCC2CC2)CCN(C1)C(C)(C)c1ccc(C)nc1 PDZAPTRDWNCSMQ-UHFFFAOYSA-N 0.000 description 1
- AFQBVVHESLFELV-UHFFFAOYSA-N 5-[2-[3-(ethoxymethyl)pyrrolidin-1-yl]propan-2-yl]-2-methylpyridine Chemical compound CCOCC1CCN(C1)C(C)(C)c1ccc(C)nc1 AFQBVVHESLFELV-UHFFFAOYSA-N 0.000 description 1
- BWLUSAFCROPUJX-LJQANCHMSA-N 5-[[(3R)-3-(ethoxymethyl)-3-(2-thiophen-2-ylethyl)pyrrolidin-1-yl]methyl]-1H-pyridin-2-one Chemical compound C(C)OC[C@]1(CN(CC1)CC=1C=CC(NC=1)=O)CCC=1SC=CC=1 BWLUSAFCROPUJX-LJQANCHMSA-N 0.000 description 1
- YNVZLRICQBVNGH-HXUWFJFHSA-N 5-[[(3R)-3-(ethoxymethyl)-3-(2-thiophen-2-ylethyl)pyrrolidin-1-yl]methyl]-2-methylpyridine Chemical compound CCOC[C@]1(CCc2cccs2)CCN(Cc2ccc(C)nc2)C1 YNVZLRICQBVNGH-HXUWFJFHSA-N 0.000 description 1
- RBQGVMBISLMTPP-OAQYLSRUSA-N 5-[[(3R)-3-(ethoxymethyl)-3-[2-(4-methylthiophen-2-yl)ethyl]pyrrolidin-1-yl]methyl]-2-methylpyridine Chemical compound CCOC[C@]1(CCc2cc(C)cs2)CCN(Cc2ccc(C)nc2)C1 RBQGVMBISLMTPP-OAQYLSRUSA-N 0.000 description 1
- ULJHZRCYMMRXQV-NRFANRHFSA-N 5-[[(3S)-3-(ethoxymethyl)-3-(phenoxymethyl)pyrrolidin-1-yl]methyl]-2-methylpyridine Chemical compound C(C)OC[C@]1(CN(CC1)CC=1C=CC(=NC=1)C)COC1=CC=CC=C1 ULJHZRCYMMRXQV-NRFANRHFSA-N 0.000 description 1
- ZYTZZAUXGNZSSC-UHFFFAOYSA-N 5-[[3-(2-cyclopropylethyl)-3-(ethoxymethyl)pyrrolidin-1-yl]methyl]-2-methylpyridine Chemical compound CCOCC1(CCC2CC2)CCN(Cc2ccc(C)nc2)C1 ZYTZZAUXGNZSSC-UHFFFAOYSA-N 0.000 description 1
- MKALQORCYSRMGN-UHFFFAOYSA-N 5-[[3-(ethoxymethyl)-3-(2-thiophen-2-ylethyl)azetidin-1-yl]methyl]-2-methylpyridine Chemical compound CCOCC1(CCc2cccs2)CN(Cc2ccc(C)nc2)C1 MKALQORCYSRMGN-UHFFFAOYSA-N 0.000 description 1
- NVYHPMKPZDWOAU-UHFFFAOYSA-N 5-[[3-(ethoxymethyl)-3-[2-(5-fluorothiophen-2-yl)ethyl]pyrrolidin-1-yl]methyl]-2-methylpyridine Chemical compound CCOCC1(CCc2ccc(F)s2)CCN(Cc2ccc(C)nc2)C1 NVYHPMKPZDWOAU-UHFFFAOYSA-N 0.000 description 1
- LXUVOYAUCLBTFZ-UHFFFAOYSA-N 5-[[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]methyl]-1,3-dihydrobenzimidazol-2-one Chemical compound CCOCC1(CCC2=CC=CC=C2)CCN(CC2=CC3=C(NC(=O)N3)C=C2)CC1 LXUVOYAUCLBTFZ-UHFFFAOYSA-N 0.000 description 1
- YHHGNOVUMMEVSQ-UHFFFAOYSA-N 5-ethenyl-1,3-dihydrobenzimidazol-2-one Chemical compound C=CC1=CC=C2NC(=O)NC2=C1 YHHGNOVUMMEVSQ-UHFFFAOYSA-N 0.000 description 1
- LHOHUTABEAPMCQ-UHFFFAOYSA-N 5-ethoxy-1h-1,2,4-triazole Chemical compound CCOC=1N=CNN=1 LHOHUTABEAPMCQ-UHFFFAOYSA-N 0.000 description 1
- CWDWFSXUQODZGW-UHFFFAOYSA-N 5-thiazolyl Chemical group [C]1=CN=CS1 CWDWFSXUQODZGW-UHFFFAOYSA-N 0.000 description 1
- RZOKQIPOABEQAM-UHFFFAOYSA-N 6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC=C(C(O)=O)C=N1 RZOKQIPOABEQAM-UHFFFAOYSA-N 0.000 description 1
- SFSHVFSBHNEVKE-UHFFFAOYSA-N 7-[(4-methoxyphenyl)methyl]purine Chemical compound COC1=CC=C(C=C1)CN2C=NC3=NC=NC=C32 SFSHVFSBHNEVKE-UHFFFAOYSA-N 0.000 description 1
- QCHKRRGVZYSOTI-HSZRJFAPSA-N 8-[2-[(3R)-3-(ethoxymethyl)-1-[2-(6-methylpyridin-3-yl)propan-2-yl]pyrrolidin-3-yl]ethyl]-7H-purine Chemical compound C(C)OC[C@]1(CN(CC1)C(C)(C)C=1C=NC(=CC=1)C)CCC1=NC2=NC=NC=C2N1 QCHKRRGVZYSOTI-HSZRJFAPSA-N 0.000 description 1
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 102400000748 Beta-endorphin Human genes 0.000 description 1
- 101800005049 Beta-endorphin Proteins 0.000 description 1
- OUEGHZYBWJTUAD-UHFFFAOYSA-L Br[Mg]CCCCC[Mg]Br Chemical compound Br[Mg]CCCCC[Mg]Br OUEGHZYBWJTUAD-UHFFFAOYSA-L 0.000 description 1
- WSDCNXZBECAMKJ-UHFFFAOYSA-N C(C)OCC1(CCN(CC1)CC1=CC=C(C=C1)C#C[Si](C)(C)C)CCC1=CC=CC=C1 Chemical compound C(C)OCC1(CCN(CC1)CC1=CC=C(C=C1)C#C[Si](C)(C)C)CCC1=CC=CC=C1 WSDCNXZBECAMKJ-UHFFFAOYSA-N 0.000 description 1
- RYKQGOWYVLYHJP-CYBMUJFWSA-N C(C)OC[C@]1(CN(CC1)C(=O)OC(C)(C)C)CO Chemical compound C(C)OC[C@]1(CN(CC1)C(=O)OC(C)(C)C)CO RYKQGOWYVLYHJP-CYBMUJFWSA-N 0.000 description 1
- QGALSMWDSXFNAC-UHFFFAOYSA-N C(Cc1ccsc1)N1CCCCC1 Chemical compound C(Cc1ccsc1)N1CCCCC1 QGALSMWDSXFNAC-UHFFFAOYSA-N 0.000 description 1
- YPZCQZDSVLONHR-UHFFFAOYSA-N C1N(C(=O)OC(C)(C)C)CCC1CCC1=CC=CC=C1 Chemical compound C1N(C(=O)OC(C)(C)C)CCC1CCC1=CC=CC=C1 YPZCQZDSVLONHR-UHFFFAOYSA-N 0.000 description 1
- JGLMVXWAHNTPRF-CMDGGOBGSA-N CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O Chemical compound CCN1N=C(C)C=C1C(=O)NC1=NC2=CC(=CC(OC)=C2N1C\C=C\CN1C(NC(=O)C2=CC(C)=NN2CC)=NC2=CC(=CC(OCCCN3CCOCC3)=C12)C(N)=O)C(N)=O JGLMVXWAHNTPRF-CMDGGOBGSA-N 0.000 description 1
- XCEPIDDUDJCRNB-UHFFFAOYSA-N CCOCC1(CCC2=CC=CC=C2)CCN(CC2=CC=C(C=C2)C2=NNC(=O)N2)CC1 Chemical compound CCOCC1(CCC2=CC=CC=C2)CCN(CC2=CC=C(C=C2)C2=NNC(=O)N2)CC1 XCEPIDDUDJCRNB-UHFFFAOYSA-N 0.000 description 1
- IFYSVMGEVKDEIA-LJQANCHMSA-N CCOC[C@@]1(CCc2ccc(C)[s]2)CN(Cc2c[n](C)nc2)CC1 Chemical compound CCOC[C@@]1(CCc2ccc(C)[s]2)CN(Cc2c[n](C)nc2)CC1 IFYSVMGEVKDEIA-LJQANCHMSA-N 0.000 description 1
- OKTJSMMVPCPJKN-NJFSPNSNSA-N Carbon-14 Chemical compound [14C] OKTJSMMVPCPJKN-NJFSPNSNSA-N 0.000 description 1
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 238000006646 Dess-Martin oxidation reaction Methods 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 108010065372 Dynorphins Proteins 0.000 description 1
- 108010092674 Enkephalins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- 239000007818 Grignard reagent Substances 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- WZELXJBMMZFDDU-UHFFFAOYSA-N Imidazol-2-one Chemical compound O=C1N=CC=N1 WZELXJBMMZFDDU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical class C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 1
- 229910010082 LiAlH Inorganic materials 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- QENGPZGAWFQWCZ-UHFFFAOYSA-N Methylthiophene Natural products CC=1C=CSC=1 QENGPZGAWFQWCZ-UHFFFAOYSA-N 0.000 description 1
- 241001139947 Mida Species 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 238000006751 Mitsunobu reaction Methods 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- BNASJRRDOUXVDJ-UHFFFAOYSA-N N,N-dimethyl-4-(2-phenylethyl)piperidine-4-carboxamide Chemical compound CN(C(=O)C1(CCNCC1)CCC1=CC=CC=C1)C BNASJRRDOUXVDJ-UHFFFAOYSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N N,N′-Dicyclohexylcarbodiimide Substances C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- GJCOTRQYAWNAHX-UHFFFAOYSA-N N-[4-[(4-benzoyl-4-pyridin-2-ylpiperidin-1-yl)methyl]phenyl]acetamide Chemical compound C(C1=CC=CC=C1)(=O)C1(CCN(CC1)CC1=CC=C(C=C1)NC(C)=O)C1=NC=CC=C1 GJCOTRQYAWNAHX-UHFFFAOYSA-N 0.000 description 1
- WYFBTEOLKKJUMX-UHFFFAOYSA-N N-[4-[4-(2-phenylethyl)-4-pyridin-2-ylpiperidin-1-yl]butyl]acetamide Chemical compound CC(=O)NCCCCN1CCC(CCc2ccccc2)(CC1)c1ccccn1 WYFBTEOLKKJUMX-UHFFFAOYSA-N 0.000 description 1
- SBCURXDFDMVUSP-UHFFFAOYSA-N N-[4-[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]phenyl]acetamide Chemical compound C(C)OCC1(CCN(CC1)C1=CC=C(C=C1)NC(C)=O)CCC1=CC=CC=C1 SBCURXDFDMVUSP-UHFFFAOYSA-N 0.000 description 1
- QXXXYJONBBFSFJ-UHFFFAOYSA-N N-[4-[[3-(ethoxymethyl)-3-(2-phenylethyl)pyrrolidin-1-yl]methyl]phenyl]pyrimidin-2-amine Chemical compound C(C)OCC1(CN(CC1)CC1=CC=C(C=C1)NC1=NC=CC=N1)CCC1=CC=CC=C1 QXXXYJONBBFSFJ-UHFFFAOYSA-N 0.000 description 1
- IZBARDLIYHLGAE-UHFFFAOYSA-N N-[4-[[4-(1,3,4-oxadiazol-2-yl)-4-(2-phenylethyl)piperidin-1-yl]methyl]phenyl]acetamide Chemical compound O1C(=NN=C1)C1(CCN(CC1)CC1=CC=C(C=C1)NC(C)=O)CCC1=CC=CC=C1 IZBARDLIYHLGAE-UHFFFAOYSA-N 0.000 description 1
- ULWXWWFYHUNSDE-UHFFFAOYSA-N N-[4-[[4-(2-methoxyethyl)-4-(2-phenylethyl)piperidin-1-yl]methyl]phenyl]acetamide Chemical compound COCCC1(CCN(CC1)CC1=CC=C(C=C1)NC(C)=O)CCC1=CC=CC=C1 ULWXWWFYHUNSDE-UHFFFAOYSA-N 0.000 description 1
- IOHKDQKHMQQFTQ-UHFFFAOYSA-N N-[4-[[4-(5-methyl-1,2,4-oxadiazol-3-yl)-4-(2-phenylethyl)piperidin-1-yl]methyl]phenyl]acetamide Chemical compound CC1=NC(=NO1)C1(CCN(CC1)CC1=CC=C(C=C1)NC(C)=O)CCC1=CC=CC=C1 IOHKDQKHMQQFTQ-UHFFFAOYSA-N 0.000 description 1
- GRMKWAHIBGFBGB-UHFFFAOYSA-N N-[4-[[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]methyl]cyclohexyl]acetamide Chemical compound C(C)OCC1(CCN(CC1)CC1CCC(CC1)NC(C)=O)CCC1=CC=CC=C1 GRMKWAHIBGFBGB-UHFFFAOYSA-N 0.000 description 1
- NWVQBZCVDHZESA-UHFFFAOYSA-N N-[[4-[[4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]methyl]benzoyl]amino]formamide Chemical compound C(C)OCC1(CCN(CC1)CC1=CC=C(C(=O)NNC=O)C=C1)CCC1=CC=CC=C1 NWVQBZCVDHZESA-UHFFFAOYSA-N 0.000 description 1
- UQFQONCQIQEYPJ-UHFFFAOYSA-N N-methylpyrazole Chemical compound CN1C=CC=N1 UQFQONCQIQEYPJ-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- QYXDNVMYDOXTSG-GOSISDBHSA-N OC[C@](CCc1ccc[s]1)(CC1)CN1C1(CC1)c1cccnc1 Chemical compound OC[C@](CCc1ccc[s]1)(CC1)CN1C1(CC1)c1cccnc1 QYXDNVMYDOXTSG-GOSISDBHSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 102000005583 Pyrin Human genes 0.000 description 1
- 108010059278 Pyrin Proteins 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- 206010057362 Underdose Diseases 0.000 description 1
- PNDPGZBMCMUPRI-XXSWNUTMSA-N [125I][125I] Chemical compound [125I][125I] PNDPGZBMCMUPRI-XXSWNUTMSA-N 0.000 description 1
- PZOTXXRWCKDMBC-UHFFFAOYSA-N [3-(cyclohexylcarbamoyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=CC(C(=O)NC2CCCCC2)=C1 PZOTXXRWCKDMBC-UHFFFAOYSA-N 0.000 description 1
- XASBEAPSERBHDR-UHFFFAOYSA-N [4-(ethoxymethyl)-4-(2-phenylethyl)piperidin-1-yl]-(6-methylpyridin-3-yl)methanone Chemical compound CCOCC1(CCc2ccccc2)CCN(CC1)C(=O)c1ccc(C)nc1 XASBEAPSERBHDR-UHFFFAOYSA-N 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 150000001263 acyl chlorides Chemical class 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- 125000005263 alkylenediamine group Chemical group 0.000 description 1
- 125000005530 alkylenedioxy group Chemical group 0.000 description 1
- 125000005529 alkyleneoxy group Chemical group 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000004645 aluminates Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 125000005165 aryl thioxy group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000037424 autonomic function Effects 0.000 description 1
- BNGCVNHMPJGSOA-UHFFFAOYSA-N azidophosphonic acid Chemical compound OP(O)(=O)N=[N+]=[N-] BNGCVNHMPJGSOA-UHFFFAOYSA-N 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- MYONAGGJKCJOBT-UHFFFAOYSA-N benzimidazol-2-one Chemical compound C1=CC=CC2=NC(=O)N=C21 MYONAGGJKCJOBT-UHFFFAOYSA-N 0.000 description 1
- WARCRYXKINZHGQ-UHFFFAOYSA-N benzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1 WARCRYXKINZHGQ-UHFFFAOYSA-N 0.000 description 1
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 1
- WTEPWWCRWNCUNA-UHFFFAOYSA-M benzyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)CC1=CC=CC=C1 WTEPWWCRWNCUNA-UHFFFAOYSA-M 0.000 description 1
- WOPZMFQRCBYPJU-NTXHZHDSSA-N beta-endorphin Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C1=CC=CC=C1 WOPZMFQRCBYPJU-NTXHZHDSSA-N 0.000 description 1
- MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- 125000000319 biphenyl-4-yl group Chemical group [H]C1=C([H])C([H])=C([H])C([H])=C1C1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 125000002837 carbocyclic group Chemical group 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- LADPCMZCENPFGV-UHFFFAOYSA-N chloromethoxymethylbenzene Chemical compound ClCOCC1=CC=CC=C1 LADPCMZCENPFGV-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000019771 cognition Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- WZHCOOQXZCIUNC-UHFFFAOYSA-N cyclandelate Chemical compound C1C(C)(C)CC(C)CC1OC(=O)C(O)C1=CC=CC=C1 WZHCOOQXZCIUNC-UHFFFAOYSA-N 0.000 description 1
- 150000003950 cyclic amides Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000392 cycloalkenyl group Chemical group 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- XHFGWHUWQXTGAT-UHFFFAOYSA-N dimethylamine hydrochloride Natural products CNC(C)C XHFGWHUWQXTGAT-UHFFFAOYSA-N 0.000 description 1
- IQDGSYLLQPDQDV-UHFFFAOYSA-N dimethylazanium;chloride Chemical compound Cl.CNC IQDGSYLLQPDQDV-UHFFFAOYSA-N 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- JMNJYGMAUMANNW-FIXZTSJVSA-N dynorphin a Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 JMNJYGMAUMANNW-FIXZTSJVSA-N 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000006397 emotional response Effects 0.000 description 1
- 125000002587 enol group Chemical group 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- AEOCXXJPGCBFJA-UHFFFAOYSA-N ethionamide Chemical compound CCC1=CC(C(N)=S)=CC=N1 AEOCXXJPGCBFJA-UHFFFAOYSA-N 0.000 description 1
- IVEQHAJRJRMOLN-UHFFFAOYSA-N ethoxymethyl pyrrolidine-1-carboxylate Chemical compound C(C)OCOC(=O)N1CCCC1 IVEQHAJRJRMOLN-UHFFFAOYSA-N 0.000 description 1
- OSABVSQWANTQLX-UHFFFAOYSA-M ethoxymethyl(triphenyl)phosphanium;chloride Chemical compound [Cl-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(COCC)C1=CC=CC=C1 OSABVSQWANTQLX-UHFFFAOYSA-M 0.000 description 1
- YVPJCJLMRRTDMQ-UHFFFAOYSA-N ethyl diazoacetate Chemical compound CCOC(=O)C=[N+]=[N-] YVPJCJLMRRTDMQ-UHFFFAOYSA-N 0.000 description 1
- PQVSTLUFSYVLTO-UHFFFAOYSA-N ethyl n-ethoxycarbonylcarbamate Chemical compound CCOC(=O)NC(=O)OCC PQVSTLUFSYVLTO-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 229960002428 fentanyl Drugs 0.000 description 1
- IVLVTNPOHDFFCJ-UHFFFAOYSA-N fentanyl citrate Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1N(C(=O)CC)C(CC1)CCN1CCC1=CC=CC=C1 IVLVTNPOHDFFCJ-UHFFFAOYSA-N 0.000 description 1
- XZBIXDPGRMLSTC-UHFFFAOYSA-N formohydrazide Chemical compound NNC=O XZBIXDPGRMLSTC-UHFFFAOYSA-N 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- 150000002238 fumaric acids Chemical class 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 1
- 150000004795 grignard reagents Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000004366 heterocycloalkenyl group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 210000000548 hind-foot Anatomy 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 1
- 238000006197 hydroboration reaction Methods 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000003402 intramolecular cyclocondensation reaction Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 229940044173 iodine-125 Drugs 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007951 isotonicity adjuster Substances 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- 229910000103 lithium hydride Inorganic materials 0.000 description 1
- 229940040692 lithium hydroxide monohydrate Drugs 0.000 description 1
- GLXDVVHUTZTUQK-UHFFFAOYSA-M lithium hydroxide monohydrate Substances [Li+].O.[OH-] GLXDVVHUTZTUQK-UHFFFAOYSA-M 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- RMGJCSHZTFKPNO-UHFFFAOYSA-M magnesium;ethene;bromide Chemical compound [Mg+2].[Br-].[CH-]=C RMGJCSHZTFKPNO-UHFFFAOYSA-M 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000005649 metathesis reaction Methods 0.000 description 1
- HNQIVZYLYMDVSB-UHFFFAOYSA-N methanesulfonimidic acid Chemical compound CS(N)(=O)=O HNQIVZYLYMDVSB-UHFFFAOYSA-N 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 description 1
- SURZCVYFPAXNGN-UHFFFAOYSA-N methyl-carbamic acid ethyl ester Chemical compound CCOC(=O)NC SURZCVYFPAXNGN-UHFFFAOYSA-N 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000007932 molded tablet Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000006682 monohaloalkyl group Chemical group 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 125000004572 morpholin-3-yl group Chemical group N1C(COCC1)* 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 125000005489 p-toluenesulfonic acid group Chemical class 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 125000001151 peptidyl group Chemical group 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- PWMLLHLLENZZLW-UHFFFAOYSA-N phenoxymethyl pyrrolidine-1-carboxylate Chemical compound O(C1=CC=CC=C1)COC(=O)N1CCCC1 PWMLLHLLENZZLW-UHFFFAOYSA-N 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- KLUCWWVQVUXBSE-UHFFFAOYSA-N phenylethylpyrrolidine Chemical compound C1CCCN1CCC1=CC=CC=C1 KLUCWWVQVUXBSE-UHFFFAOYSA-N 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- IPNPIHIZVLFAFP-UHFFFAOYSA-N phosphorus tribromide Chemical compound BrP(Br)Br IPNPIHIZVLFAFP-UHFFFAOYSA-N 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 125000006684 polyhaloalkyl group Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 125000005767 propoxymethyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])[#8]C([H])([H])* 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- CPNGPNLZQNNVQM-UHFFFAOYSA-N pteridine Chemical compound N1=CN=CC2=NC=CN=C21 CPNGPNLZQNNVQM-UHFFFAOYSA-N 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- XFTQRUTUGRCSGO-UHFFFAOYSA-N pyrazin-2-amine Chemical compound NC1=CN=CC=N1 XFTQRUTUGRCSGO-UHFFFAOYSA-N 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 description 1
- 125000006514 pyridin-2-ylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 1
- QJZUKDFHGGYHMC-UHFFFAOYSA-N pyridine-3-carbaldehyde Chemical compound O=CC1=CC=CN=C1 QJZUKDFHGGYHMC-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000005344 pyridylmethyl group Chemical group [H]C1=C([H])C([H])=C([H])C(=N1)C([H])([H])* 0.000 description 1
- FDDQRDMHICUGQC-UHFFFAOYSA-M pyrrole-1-carboxylate Chemical compound [O-]C(=O)N1C=CC=C1 FDDQRDMHICUGQC-UHFFFAOYSA-M 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- JWVCLYRUEFBMGU-UHFFFAOYSA-N quinazoline Chemical compound N1=CN=CC2=CC=CC=C21 JWVCLYRUEFBMGU-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000006268 reductive amination reaction Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000006798 ring closing metathesis reaction Methods 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000010956 selective crystallization Methods 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000011044 succinic acid Nutrition 0.000 description 1
- 150000003444 succinic acids Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid group Chemical class S(N)(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 238000003419 tautomerization reaction Methods 0.000 description 1
- CKAPNPNLDLPKMH-CYBMUJFWSA-N tert-butyl (3S)-3-(ethoxymethyl)-3-formylpyrrolidine-1-carboxylate Chemical compound C(C)OC[C@]1(CN(CC1)C(=O)OC(C)(C)C)C=O CKAPNPNLDLPKMH-CYBMUJFWSA-N 0.000 description 1
- CQIHFWDTLVWATL-UHFFFAOYSA-N tert-butyl 2-(2-phenylethyl)pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCC1CCC1=CC=CC=C1 CQIHFWDTLVWATL-UHFFFAOYSA-N 0.000 description 1
- YDBPZCVWPFMBDH-UHFFFAOYSA-N tert-butyl 2-formylpyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCCC1C=O YDBPZCVWPFMBDH-UHFFFAOYSA-N 0.000 description 1
- CKAPNPNLDLPKMH-UHFFFAOYSA-N tert-butyl 3-(ethoxymethyl)-3-formylpyrrolidine-1-carboxylate Chemical compound C(C)OCC1(CN(CC1)C(=O)OC(C)(C)C)C=O CKAPNPNLDLPKMH-UHFFFAOYSA-N 0.000 description 1
- ISJSLKYJGIZHLX-UHFFFAOYSA-N tert-butyl 3-formyl-3-(2-phenylethyl)pyrrolidine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCC(CCc2ccccc2)(C1)C=O ISJSLKYJGIZHLX-UHFFFAOYSA-N 0.000 description 1
- WJOJDEXNCJFKAH-UHFFFAOYSA-N tert-butyl 4-(2,5-dihydrofuran-2-yl)-4-(2-phenylethyl)piperidine-1-carboxylate Chemical compound O1C(C=CC1)C1(CCN(CC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 WJOJDEXNCJFKAH-UHFFFAOYSA-N 0.000 description 1
- BBSLLYWVZCTUKE-UHFFFAOYSA-N tert-butyl 4-(ethoxymethyl)-4-(2-phenylethyl)azepane-1-carboxylate Chemical compound C(C)OCC1(CCN(CCC1)C(=O)OC(C)(C)C)CCC1=CC=CC=C1 BBSLLYWVZCTUKE-UHFFFAOYSA-N 0.000 description 1
- HQBBSADRDMVIGK-UHFFFAOYSA-N tert-butyl 4-cyano-4-(2-phenylethyl)piperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(C#N)CCC1=CC=CC=C1 HQBBSADRDMVIGK-UHFFFAOYSA-N 0.000 description 1
- LWEUZOXYUOEMQN-UHFFFAOYSA-N tert-butyl 4-hydroxy-4-thiophen-2-ylpiperidine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCC1(O)C1=CC=CS1 LWEUZOXYUOEMQN-UHFFFAOYSA-N 0.000 description 1
- RUPAXCPQAAOIPB-UHFFFAOYSA-N tert-butyl formate Chemical compound CC(C)(C)OC=O RUPAXCPQAAOIPB-UHFFFAOYSA-N 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 238000011287 therapeutic dose Methods 0.000 description 1
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
- 125000001113 thiadiazolyl group Chemical group 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 230000009974 thixotropic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 239000012049 topical pharmaceutical composition Substances 0.000 description 1
- 125000005490 tosylate group Chemical group 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 125000001889 triflyl group Chemical group FC(F)(F)S(*)(=O)=O 0.000 description 1
- SEDZOYHHAIAQIW-UHFFFAOYSA-N trimethylsilyl azide Chemical compound C[Si](C)(C)N=[N+]=[N-] SEDZOYHHAIAQIW-UHFFFAOYSA-N 0.000 description 1
- LEIMLDGFXIOXMT-UHFFFAOYSA-N trimethylsilyl cyanide Chemical compound C[Si](C)(C)C#N LEIMLDGFXIOXMT-UHFFFAOYSA-N 0.000 description 1
- CWMFRHBXRUITQE-UHFFFAOYSA-N trimethylsilylacetylene Chemical compound C[Si](C)(C)C#C CWMFRHBXRUITQE-UHFFFAOYSA-N 0.000 description 1
- BPLKQGGAXWRFOE-UHFFFAOYSA-M trimethylsulfoxonium iodide Chemical compound [I-].C[S+](C)(C)=O BPLKQGGAXWRFOE-UHFFFAOYSA-M 0.000 description 1
- RIOQSEWOXXDEQQ-UHFFFAOYSA-O triphenylphosphanium Chemical compound C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-O 0.000 description 1
- 229910052722 tritium Inorganic materials 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
- C01F5/00—Compounds of magnesium
- C01F5/02—Magnesia
- C01F5/04—Magnesia by oxidation of metallic magnesium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
- C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
- C07D225/02—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/056—Ortho-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/04—Esters of boric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Geology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762470281P | 2017-03-12 | 2017-03-12 | |
PCT/US2018/021906 WO2018169818A1 (en) | 2017-03-12 | 2018-03-12 | Polycyclic amines as opioid receptor modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112019018774A2 true BR112019018774A2 (pt) | 2020-04-07 |
Family
ID=63446931
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112019018774A BR112019018774A2 (pt) | 2017-03-12 | 2018-03-12 | composto tendo uma estrutura de acordo com a fórmula i, sal farmaceuticamente aceitável, composição farmacêutica, método para prevenir ou tratar uma doença ou afeção e método para imunomodulação, inibição ou prevenção de rejeição de enxertos de órgãos ou pele ou tratamento de tumores ou câncer |
Country Status (8)
Country | Link |
---|---|
US (1) | US10676456B2 (zh) |
EP (1) | EP3595661A4 (zh) |
JP (1) | JP7376358B2 (zh) |
CN (1) | CN110662541B (zh) |
AU (2) | AU2018236130A1 (zh) |
BR (1) | BR112019018774A2 (zh) |
CA (1) | CA3055215A1 (zh) |
WO (1) | WO2018169818A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109134222B (zh) * | 2018-09-14 | 2022-01-21 | 上海博栋化学科技有限公司 | 一种2-羟基异丙基取代的苯乙酮的制备方法 |
CA3121202A1 (en) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Pyrrole and pyrazole compounds and methods of use thereof |
CN111362803A (zh) * | 2018-12-25 | 2020-07-03 | 南京大学淮安高新技术研究院 | 一种连续合成1-硝基均三甲苯的微通道反应工艺 |
BR112022026413A2 (pt) * | 2020-07-01 | 2023-05-02 | Ecstasy LLC | Aminas policíclicas para modulação de receptores opióides. |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1522695A (en) * | 1921-02-14 | 1925-01-13 | Noreen William | Combination wrench and pliers |
FR2424273A1 (fr) * | 1978-04-24 | 1979-11-23 | Parcor | (thienyl-2)-3 et (thienyl-3)-3 pyrrolidines, leur procede de preparation et leur application en therapeutique |
JPS5818390A (ja) * | 1981-07-15 | 1983-02-02 | ジヤンセン・フア−マシユ−チカ・ナ−ムロ−ゼ・フエンノ−トシヤツプ | 二環式ピリミジン−5−オン誘導体、その製法および薬効成分としてのその用途 |
US20020052007A1 (en) * | 1992-02-03 | 2002-05-02 | Chang Kwen Jen | Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives |
EP0666856B1 (en) * | 1992-10-28 | 2000-01-05 | MERCK SHARP & DOHME LTD. | 4-arylmethyloxymethyl piperidines as tachykinin antagonists |
AU693936B2 (en) * | 1994-08-25 | 1998-07-09 | Merrell Pharmaceuticals Inc. | Novel substituted piperidines useful for the treatment of allergic diseases |
US5780466A (en) * | 1995-01-30 | 1998-07-14 | Sanofi | Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present |
HN1999000149A (es) * | 1998-09-09 | 2000-01-12 | Pfizer Prod Inc | Derivados de 4,4-biarilpiperidina |
KR100602929B1 (ko) * | 2000-08-31 | 2006-07-20 | 에프. 호프만-라 로슈 아게 | 알파-1 아드레날린성 길항제로서 퀴나졸린 유도체 |
WO2002050070A2 (en) * | 2000-12-21 | 2002-06-27 | Warner-Lambert Company Llc | Piperidine derivatives as subtype selective n-methyl-d-aspartate antagonists |
US6995144B2 (en) * | 2002-03-14 | 2006-02-07 | Eisai Co., Ltd. | Nitrogen containing heterocyclic compounds and medicines containing the same |
US20040204453A1 (en) * | 2003-04-14 | 2004-10-14 | Pfizer Inc | 4-Phenyl-piperidine compounds and their use as modulators of opioid receptors |
US7098203B2 (en) * | 2004-07-20 | 2006-08-29 | Bristol-Myers Squibb Company | Homopiperidine derivatives as NK-1 antagonists |
EP1987001B1 (en) * | 2006-02-17 | 2010-05-05 | NeuroSearch A/S | 1-phenethylpiperidine derivatives and their use as opioid receptor ligands |
US20070249607A1 (en) * | 2006-04-17 | 2007-10-25 | Bristol-Myers Squibb Company | Nk-1 and serotonin transporter inhibitors |
TWI457122B (zh) * | 2007-07-20 | 2014-10-21 | Orion Corp | 作為用於治療周邊和中央神經系統疾病之alpha2C拮抗劑的2,3-二氫苯並[1,4]戴奧辛-2-基甲基衍生物 |
CA2718736A1 (en) * | 2008-03-20 | 2009-09-24 | F. Hoffmann-La Roche Ag | Pyrrolidinyl derivatives and uses thereof |
US20150374705A1 (en) * | 2012-02-14 | 2015-12-31 | Shanghai Institues for Biological Sciences | Substances for treatment or relief of pain |
-
2018
- 2018-03-12 JP JP2019547999A patent/JP7376358B2/ja active Active
- 2018-03-12 AU AU2018236130A patent/AU2018236130A1/en not_active Abandoned
- 2018-03-12 WO PCT/US2018/021906 patent/WO2018169818A1/en unknown
- 2018-03-12 BR BR112019018774A patent/BR112019018774A2/pt active Search and Examination
- 2018-03-12 CA CA3055215A patent/CA3055215A1/en active Pending
- 2018-03-12 CN CN201880030163.0A patent/CN110662541B/zh active Active
- 2018-03-12 US US15/917,866 patent/US10676456B2/en active Active
- 2018-03-12 EP EP18767997.2A patent/EP3595661A4/en active Pending
-
2022
- 2022-05-02 AU AU2022202916A patent/AU2022202916B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3595661A4 (en) | 2020-08-19 |
CA3055215A1 (en) | 2018-09-20 |
US20180258065A1 (en) | 2018-09-13 |
EP3595661A1 (en) | 2020-01-22 |
CN110662541A (zh) | 2020-01-07 |
US10676456B2 (en) | 2020-06-09 |
WO2018169818A1 (en) | 2018-09-20 |
AU2022202916B2 (en) | 2024-02-29 |
AU2018236130A1 (en) | 2019-09-19 |
JP7376358B2 (ja) | 2023-11-08 |
CN110662541B (zh) | 2023-02-10 |
AU2022202916A1 (en) | 2022-05-26 |
JP2020510007A (ja) | 2020-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA3124898C (en) | Heterocyclic compound, intermediate, preparation method therefor and application thereof | |
ES2682282T3 (es) | Compuestos bicíclicos sustituidos con sulfonilo como moduladores de PPAR | |
AU2015240519B2 (en) | Substituted spirocyclic inhibitors of autotaxin | |
BR112019018774A2 (pt) | composto tendo uma estrutura de acordo com a fórmula i, sal farmaceuticamente aceitável, composição farmacêutica, método para prevenir ou tratar uma doença ou afeção e método para imunomodulação, inibição ou prevenção de rejeição de enxertos de órgãos ou pele ou tratamento de tumores ou câncer | |
JP6964576B2 (ja) | 置換4−アザインドール及びglun2b受容体調節因子としてのそれらの使用 | |
KR20110036044A (ko) | 벤즈아제핀 유도체들 및 히스타민 h3 길항제로서 이들의 용도 | |
JP2024054409A (ja) | 心筋サルコメア阻害剤 | |
CA3092450A1 (en) | Piperidinyl-3-(aryloxy)propanamides and propanoates | |
CA3199496A1 (en) | Heterocycle derivatives for treating trpm3 mediated disorders | |
BR112020019818A2 (pt) | Compostos ox2r | |
JP7490647B2 (ja) | Rip1阻害剤 | |
TW202346280A (zh) | 雙重magl及faah抑制劑 | |
AU2016214802B2 (en) | Diaza-benzofluoranthrene compounds | |
WO2012075232A1 (en) | Opioid receptor ligands and methods of using and making the same | |
TW202317092A (zh) | Kif18a之吲哚啉抑制劑 | |
US20220411442A1 (en) | Polycyclic amines as opioid receptor modulators | |
WO2014051055A1 (ja) | キヌクリジンウレア誘導体及びその医薬用途 | |
JP7061663B2 (ja) | 新規な1h-ピラゾロピリジン誘導体およびこれを含む薬学組成物 | |
TW202413357A (zh) | 用於治療TRPM3介導之病症的吡唑并[1,5-a]吡啶衍生物 | |
WO2023230542A2 (en) | PYRAZOLO[1,5-a]PYRIDINE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS | |
WO2023227697A1 (en) | New derivatives for treating trpm3 mediated disorders | |
TW202412782A (zh) | 用於治療trpm3介導之病症的吲唑衍生物 | |
CN114671876A (zh) | 新型茶碱类化合物、异构体或盐及其制备方法和用途 | |
CN114656473A (zh) | 吡咯并嘧啶类化合物、异构体或盐及其制备方法和用途 | |
OA18996A (en) | Substituted Spirocyclic Inhibitors of Autotaxin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO EM FUNCAO DA REVOGACAO DO ART. 229-C DA LEI NO 9.279, DE 1996, POR FORCA DA LEI NO 14.195, DE 2021 |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B06W | Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette] |